Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1050.Time spend outdoors in summer,49663,0.0145546998703003,0.0244745982829989,-0.0334155127643776,0.0625249125049783,0.552059984939583
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1060.Time spent outdoors in winter,47580,-0.0567875328405225,0.0267909086676995,-0.109297713829214,-0.00427735185183148,0.034048357285442
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1070.Time spent watching television (TV),50844,0.0554268918312157,0.0249616231423155,0.00650211047227731,0.104351673190154,0.0263962237286206
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1080.Time spent using computer,47638,-0.0728151189450698,0.0240467181048158,-0.119946686430509,-0.0256835514596308,0.00246462066359559
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1090.Time spent driving,43520,-0.0109667892316304,0.0276472905753811,-0.0651554787593774,0.0432219002961165,0.691618375578693
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1160.Sleep duration,51628,0.0271894911875934,0.0216238670732037,-0.0151932882758858,0.0695722706510725,0.208627932306965
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35464,-0.0186397110123065,0.0233337359997791,-0.0643738335718735,0.0270944115472605,0.424418686329088
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35464,-0.0336993906399002,0.02253521306796,-0.0778684082531017,0.0104696269733014,0.134857711085446
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35464,-0.0380901765857366,0.0244967104227993,-0.0861037290144232,0.00992337584295009,0.120018009341448
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35464,-0.040279998366398,0.0244834147043642,-0.0882674911869518,0.00770749445415579,0.0999796719612984
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35464,0.00655835642110127,0.0247501866832524,-0.0419520094780734,0.0550687223202759,0.791031962394527
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35464,-0.00718258564957888,0.0621599682800368,-0.129016123478451,0.114650952179293,0.908012875094503
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35464,0.0355562590143288,0.0655181261952972,-0.0928592683284537,0.163971786357111,0.587360162511025
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35464,-0.0359373267246266,0.0418343459007813,-0.117932644690158,0.0460579912409047,0.390351944423408
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35464,0.03488517165999,0.0308603893914243,-0.0256011915472017,0.0953715348671817,0.258342935311817
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35464,-0.0075559721788265,0.0200846190462197,-0.0469218255094171,0.0318098811517641,0.706775818181322
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35464,0.0166280721497394,0.0303487698220098,-0.0428555167013999,0.0761116610008786,0.583780499032948
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35464,-0.0106622811401474,0.0161523543241099,-0.0423208956154027,0.020996333335108,0.509209454954773
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35464,-0.01450727212725,0.021205107065981,-0.0560692819765728,0.0270547377220729,0.493911746655505
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35464,0.0120581247300496,0.0304136339421332,-0.0475525977965316,0.0716688472566307,0.69177106868753
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35464,-0.0131056756231782,0.0287308165376649,-0.0694180760370015,0.0432067247906451,0.64829507165785
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35464,-0.00711150377424499,0.0438296357660567,-0.0930175898757162,0.0787945823272262,0.871111603682125
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35464,0.0290867295598109,0.0412646894511924,-0.0517920617645263,0.109965520884148,0.480909964532077
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35464,0.0152370392586539,0.0219885297295002,-0.0278604790111664,0.0583345575284742,0.488364095794375
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35464,0.00980045315692313,0.0208604213341527,-0.0310859726580162,0.0506868789718625,0.638506470342895
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35464,-0.0202930483043969,0.0263406080827233,-0.0719206401465346,0.0313345435377407,0.44108619056351
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120040.Fatigue severity over the past week,35469,0.0180979834400087,0.0437553890770446,-0.0676625791509988,0.103858546031016,0.6791685818459
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35466,-0.0339328075846663,0.0437388454299882,-0.119660944627443,0.0517953294581106,0.43789349175808
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35468,0.00275377916911775,0.0464025163535817,-0.0881951528839024,0.0937027112221378,0.952678835291652
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120098.Mobility problems today,35472,-0.0104035507445551,0.0474549083966761,-0.10341517120204,0.08260806971293,0.826477834077636
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120099.Self-care problems today,35472,-0.141795603504901,0.0745198736744362,-0.287854555906796,0.00426334889699367,0.0571137965046046
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120100.Problems doing usual activities,35472,0.0237839589731873,0.0461344483748911,-0.0666395598415993,0.114207477787974,0.606196833124465
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120101.Pain or discomfort today,35472,-0.0384781453872485,0.0439517973154499,-0.12462366812553,0.0476673773510332,0.381355875878084
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120102.Anxiety or depression today,35472,-0.0114469139062367,0.0552343922557706,-0.119706322727547,0.0968124949150737,0.835827197003764
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120103.Scale to indicate how health is today,35450,0.000948200801625186,0.00706973069500037,-0.0129084713605755,0.0148048729638259,0.893311046054357
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35448,-0.0258044817700215,0.0560908764963597,-0.135742599702887,0.0841336361628436,0.645497941939691
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35440,-0.0114177034466555,0.0585041026348071,-0.126085744610877,0.103250337717567,0.845273469757819
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35453,-0.0625124541123108,0.0441680985387204,-0.149081927248203,0.0240570190235812,0.157021403863831
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35452,-0.0569685362225893,0.0453428118491081,-0.145840447446841,0.0319033750016625,0.209019273613492
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35463,0.034402912512034,0.0642687932907896,-0.0915639223379136,0.160369747361982,0.592463276027921
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35444,-0.0373313235303335,0.0632817296195328,-0.161363513584618,0.0867008665239508,0.555263863162218
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35457,-0.0740681254640329,0.0632928673625612,-0.198122145494653,0.0499858945665871,0.241947159728105
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35455,-0.0795834802355953,0.0872222251811055,-0.250539041590562,0.0913720811193714,0.361581735860005
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35438,0.0137835194116265,0.130651359318031,-0.242293144851714,0.269860183674967,0.915983668388511
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33348,0.0596718564671669,0.0602949581938085,-0.0585062615926977,0.177849974527031,0.322395178620024
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49858,0.109374774471107,0.0525567232178724,0.0063635969640768,0.212385951978137,0.0374388180259914
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48117,0.0777643083114362,0.0333777343271992,0.0123439490301258,0.143184667592747,0.0198258203269024
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1289.Cooked vegetable intake,51183,-0.0199005286274527,0.0228244626889199,-0.0646364754977357,0.0248354182428304,0.383275331558084
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50390,-0.0795302896749334,0.0236968150613189,-0.125976047195119,-0.0330845321547483,0.000791718070617211
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1309.Fresh fruit intake,51101,-0.070243211681908,0.0235476799866726,-0.116396664455786,-0.0240897589080297,0.00285733233865544
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1319.Dried fruit intake,49929,-0.0561266995580876,0.0237981001801518,-0.102770975911185,-0.00948242320499,0.018360513338755
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X134.Number of self-reported cancers,51835,0.0681948513550838,0.0357731320082892,-0.00192048738116292,0.138310190091331,0.0566220235827934
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51836,0.035916680488133,0.0235446608879471,-0.0102308548522433,0.0820642158285093,0.12715580827538
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X136.Number of operations, self-reported",51836,0.0313334200955117,0.0225819719103347,-0.0129272448487442,0.0755940850397676,0.165290403319774
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X137.Number of treatments or medications taken,51836,0.0339375552680442,0.0225975744395682,-0.0103536906335094,0.0782288011695978,0.133156792742459
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1438.Bread intake,51223,0.00358535452326885,0.00414128846257456,-0.00453157086337729,0.011702279909915,0.38663219436713
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1458.Cereal intake,50887,-0.0308874891386752,0.0223261122598696,-0.0746466691680197,0.0128716908906692,0.16653527542759
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1488.Tea intake,51145,0.00563178258498947,0.00401569114756681,-0.00223897206424148,0.0135025372342204,0.160796797080525
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1498.Coffee intake,50169,-0.0105611712162469,0.0226949516750165,-0.0550432764992793,0.0339209340667854,0.641683285099942
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1528.Water intake,50003,-0.0996806622368407,0.0224885582080713,-0.143758236324661,-0.0556030881490209,9.36203269713984e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1568.Average weekly red wine intake,44659,-0.0769463303469692,0.0265393855861256,-0.128963526095775,-0.0249291345981629,0.00374491949179286
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44659,-0.103046309713393,0.0271758592656655,-0.156310993874098,-0.0497816255526888,0.000150108186639455
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,44705,0.0624583572315353,0.0300029135232852,0.00365264672589626,0.121264067737174,0.037382301327937
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1598.Average weekly spirits intake,44640,-0.0251112458725778,0.0284083483550443,-0.0807916086484646,0.030569116903309,0.37674292394477
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1608.Average weekly fortified wine intake,44690,0.0285178738559577,0.043123419687818,-0.0560040287321656,0.113039776444081,0.50842447498009
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1737.Childhood sunburn occasions,45647,-0.0609461740333675,0.0272653581707403,-0.114386276048018,-0.00750607201871647,0.025411219358316
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1807.Father's age at death,49735,-0.0103214988183184,0.00388787122879208,-0.0179417264267508,-0.00270127120988588,0.00794179360383611
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1845.Mother's age,32521,-0.0169742839451083,0.0179626040346047,-0.0521809878529335,0.018232419962717,0.344738208258862
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1873.Number of full brothers,51418,0.0343160431278917,0.021635358575821,-0.00808925968071746,0.076721345936501,0.112728748723446
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1883.Number of full sisters,51424,-0.0310028988276333,0.0217363944685368,-0.0736062319859654,0.0116004343306989,0.153792099617378
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20015.Sitting height,51674,0.0042224964837296,0.00519343413470115,-0.00595663442028465,0.0144016273877438,0.416200777516573
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20016.Fluid intelligence score,36579,-0.0561218160747082,0.0354022707213758,-0.125510266688605,0.0132666345391884,0.112950079212655
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20018.Prospective memory result,36931,0.133432494161301,0.04298502916136,0.0491818370050354,0.217683151317567,0.00191507663551323
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36458,-0.0119058086865498,0.00694663051705294,-0.0255212044999735,0.00170958712687397,0.0865903201011057
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36444,0.00278690143711766,0.00700723365617833,-0.0109472765289919,0.0165210794032272,0.690849936745121
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20023.Mean time to correctly identify matches,51533,0.0089941837342239,0.00422665536009499,0.000709939228437727,0.0172784282400101,0.0333507244660693
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48458,0.00548650058904601,0.00874249506252479,-0.0116487897335026,0.0226217909115946,0.530295131450337
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48008,-0.0566989970174515,0.0185945615015112,-0.0931443375604135,-0.0202536564744896,0.00229751568009339
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47975,-0.00354088758995107,0.0248034886537549,-0.0521557253513106,0.0450739501714085,0.886483121399909
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47982,0.0308654064857234,0.0238980372601722,-0.0159747465442142,0.0777055595156609,0.196530418761179
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48005,-0.0241269789344598,0.0165008678970596,-0.0564686800126966,0.0082147221437771,0.143712914371977
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48175,0.00155511976979155,0.0109752588615284,-0.0199563875988042,0.0230666271383873,0.887323834231239
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48123,-0.0105074372842913,0.0134758339557758,-0.0369200718376118,0.0159051972690291,0.435562829993895
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48024,0.00961716260374464,0.0174905040829416,-0.0246642253988208,0.0438985506063101,0.582428432033267
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48175,0.0126187861296706,0.011875891482143,-0.0106579611753296,0.0358955334346709,0.287997388318392
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48165,-0.0154592998801238,0.0110360856090784,-0.0370900276739175,0.00617142791366986,0.161291568739476
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48049,-0.00866295878761047,0.0157103110512658,-0.0394551684480914,0.0221292508728704,0.581353241108983
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49550,0.0101887236698026,0.00961209021282171,-0.00865097314732796,0.0290284204869331,0.289161528414679
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49390,-0.00165850076227414,0.0124960694892625,-0.0261507969612287,0.0228337954366804,0.894414728366197
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49302,0.00435480201220781,0.0276533290457885,-0.0498457229175376,0.0585553269419532,0.874869410994071
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49326,-0.00728761912836756,0.0173659360557358,-0.0413248537976097,0.0267496155408746,0.674745463421577
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49480,0.00471305824256315,0.0105092758065099,-0.0158851223381963,0.0253112388233226,0.653821340677385
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49347,0.000191127813015391,0.0201993485483572,-0.0393995953417646,0.0397818509677954,0.992450560302052
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49331,0.00734217483052092,0.0169828196674833,-0.0259441517177463,0.0406285013787881,0.665506540604382
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49337,-0.0404088764984396,0.0149545144584605,-0.0697197248370221,-0.0110980281598571,0.00689568182787608
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49384,0.0502828408846702,0.0168258453822244,0.0173041839355104,0.0832614978338299,0.00280753137945672
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49524,-0.00858886145416336,0.00934110784694171,-0.0268974328341691,0.00971970992584239,0.357861089900836
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49396,-0.00432336823536719,0.0142938950768318,-0.0323394025859575,0.0236926661152231,0.762302576984492
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45821,0.0210540926746732,0.0120590488703221,-0.00258164311115807,0.0446898284605045,0.0808439272088278
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45649,-0.000125357082166192,0.0421901108451472,-0.0828179743386546,0.0825672601743223,0.997629330388693
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45639,-0.0354309242057961,0.0445726884533587,-0.122793393574379,0.051931545162787,0.426681917189226
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45672,-0.0195599580996293,0.0183713710356289,-0.055567845329462,0.0164479291302034,0.287028312430707
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45666,0.0356598297859239,0.0249482767232331,-0.013238792591613,0.0845584521634608,0.152922505504306
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45699,-0.01744140918879,0.0199585881602862,-0.056560241982951,0.021677423605371,0.382196371975258
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45662,0.0473764990229539,0.0223425408765791,0.00358511890485878,0.091167879141049,0.0339820473116484
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45657,-0.00747336229131605,0.0227584138733465,-0.0520798534830753,0.0371331289004432,0.74263005605498
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45676,0.00191378657479683,0.0183983379700281,-0.0341469558464583,0.037974528996052,0.917155110984992
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45692,-0.0131943203104749,0.021677328604226,-0.0556818843747579,0.029293243753808,0.542752165930662
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,45865,-0.0121793332145626,0.0101123362473989,-0.0319995122594644,0.00764084583033918,0.228450756883034
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45758,-0.0159284056947137,0.0139561980544199,-0.0432825538813768,0.0114257424919494,0.25375573413566
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20127.Neuroticism score,46965,0.0238690625002891,0.0227842404103901,-0.0207880487040755,0.0685261737046536,0.294831281939313
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36579,-0.0451015881345705,0.0360750056859752,-0.115808599279082,0.0256054230099409,0.211259933258366
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20161.Pack years of smoking,36872,0.0691409404559189,0.00722063020456618,0.0549885052549692,0.0832933756568686,1.33814416826937e-21
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36872,0.0719255484256085,0.00745661693806648,0.0573105792269982,0.0865405176242188,6.809101577591e-22
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20191.Fluid intelligence score,34244,0.0317093382924266,0.0453804387457039,-0.057236321649153,0.120654998234006,0.484743885117623
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34245,0.0461046859879171,0.0461876635884194,-0.0444231346453849,0.136632506621219,0.318228635840731
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20240.Maximum digits remembered correctly,33617,0.0343600142424062,0.0492601441104238,-0.0621898682140244,0.130909896698837,0.485513159678226
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20255.Spirometry QC measure,45913,0.00297461885722142,0.0289850054918443,-0.0538359919067934,0.0597852296212362,0.918260936556615
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20261.avMSE,34237,-0.000326049067938233,0.00771682922467676,-0.0154510343483047,0.0147989362124282,0.966299730186744
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20262.Myopia diagnosis,34237,-0.0148924483055674,0.0575480234645282,-0.127686574296043,0.0979016776849079,0.795813263616519
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20280.Glucose-lactate,42313,0.000641579169417531,0.0051418995503631,-0.00943654394929415,0.0107197022881292,0.900703798943607
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42341,0.00620942383880643,0.00527557371174734,-0.00413070063621835,0.0165495483138312,0.239211247940417
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36281,-0.0389307342845866,0.0325747565821373,-0.102777257185576,0.0249157886164025,0.232080245571555
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36281,-0.0594027039175382,0.061125493414911,-0.179208671010764,0.0604032631756874,0.331175493722036
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36281,0.0237108497900395,0.10188428007176,-0.17598233915061,0.223404038730689,0.815982965712785
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36281,-0.0575924098570079,0.0298628942651778,-0.116123682616756,0.000938862902740568,0.0538252925024756
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36281,-0.094246663087873,0.0613358626800612,-0.214464953940793,0.0259716277650471,0.124444018073693
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36285,-0.134862489990746,0.0784839442159011,-0.288691020653913,0.0189660406724197,0.0857773652050102
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36285,-0.0842546715142273,0.0484589730569267,-0.179234258705804,0.0107249156773491,0.0821343794608925
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36285,0.0418736578213899,0.0591119824498879,-0.0739858277803904,0.15773314342317,0.478733521353943
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36285,0.0624343552941726,0.0934034170070793,-0.120636342039703,0.245505052628048,0.503876062748251
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36285,-0.180110275780242,0.1068780412548,-0.38959123663965,0.0293706850791666,0.0919950738722437
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36285,0.0176447024624821,0.0635261672141567,-0.106866585277265,0.142155990202229,0.781208632649707
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36285,-0.0991131389593877,0.110741943960645,-0.316167349122252,0.117941071203476,0.370821814488045
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36285,-0.0524882446744162,0.0757908483346708,-0.201038307410371,0.0960618180615384,0.488620534463738
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36283,0.0398234577023709,0.105078118301349,-0.166129654168274,0.245776569573016,0.704707335192634
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36283,-0.0734629423863998,0.0404638126931466,-0.152772015264967,0.00584613049216748,0.0694859588259308
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36283,-0.068989206473369,0.0739138307569143,-0.213860314756921,0.0758819018101831,0.350658977865842
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36285,-0.0330158282856541,0.128757007516572,-0.285379563018135,0.219347906446827,0.797634246196242
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20600.Liking for adding salt to foods,36100,0.136626340462083,0.0385482730769538,0.0610717252312532,0.212180955692912,0.000396276115321452
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20601.Liking for aniseed,36100,-0.0356769243662807,0.0380126097326558,-0.110181639442286,0.0388277907097247,0.34799213952201
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20602.Liking for apple juice,36100,-0.0110570791393301,0.0384405336185918,-0.08640052503177,0.0642863667531098,0.773630087523995
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20603.Liking for apples,36100,-0.15246788610437,0.0391478932356628,-0.229197756846269,-0.0757380153624705,9.92639613007841e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20604.Liking for asparagus,36100,-0.115557676488046,0.0387041973043615,-0.191417903204594,-0.0396974497714971,0.00283958249826955
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20605.Liking for aubergine,36100,-0.125422298320662,0.0383465318904448,-0.200581500825934,-0.0502630958153906,0.00107785674252016
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20606.Liking for avocados,36100,-0.0718931124474741,0.0389814541925548,-0.148296762664882,0.00451053776993333,0.0651837238198747
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20607.Liking for bacon,36100,0.0370239594856196,0.03914800008462,-0.0397061206802357,0.113754039651475,0.344312653427049
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36100,-0.0164746447350444,0.039163758464856,-0.0932356113261622,0.0602863218560735,0.674016142517381
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20609.Liking for bananas,36100,-0.0213602658431427,0.0398240244582636,-0.0994153537813394,0.056694822095054,0.591722695337372
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36100,-0.0278581420744912,0.0386428756152042,-0.103598178280291,0.047881894131309,0.470987626443381
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20611.Liking for beef steak,36100,-0.0561511345488064,0.0386935152989529,-0.131990424534754,0.0196881554371414,0.146776095111581
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20612.Liking for beetroot,36100,-0.0226004902138915,0.0386517716261843,-0.0983579626012128,0.0531569821734298,0.558754672541701
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20613.Liking for bell pepper,36100,-0.087636380403054,0.0383977315749355,-0.162895934289928,-0.0123768265161803,0.0225000426401702
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20614.Liking for bicycling,36100,-0.051202955158121,0.0382739118603294,-0.126219822404367,0.0238139120881245,0.18100476341455
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20615.Liking for biscuits,36100,0.00997345003937839,0.0385826793730722,-0.0656486015318432,0.0855955016105999,0.796032213958158
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20616.Liking for bitter foods,36100,0.0185898855942259,0.0384380721267502,-0.0567487357742044,0.0939285069626563,0.628662342117968
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20617.Liking for bitter or ale,36100,0.00114196078352188,0.0392740302267789,-0.0758351384609647,0.0781190600280085,0.97680422766228
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20618.Liking for black olives,36100,-0.0745903274699982,0.0384778010497379,-0.150006817527484,0.000826162587488008,0.0525994829071856
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20619.Liking for black pepper,36100,-0.0646252249082338,0.0386303550662002,-0.140340720837986,0.0110902710215185,0.0943897678480005
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20620.Liking for blue cheese,36100,-0.0277745040402596,0.0386149132427103,-0.103459733995972,0.0479107259154526,0.471999657449064
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20621.Liking for bolognese sauce,36100,-0.00198584651633385,0.0386143907198507,-0.0776700523272412,0.0736983592945735,0.958986259337232
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20622.Liking for broad beans,36100,-0.0948123905861673,0.0386064552719404,-0.17048104291917,-0.0191437382531642,0.0140789303310918
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20623.Liking for broccoli,36100,-0.104551573034461,0.0401302864594963,-0.183206934495074,-0.025896211573848,0.00919900641831433
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20624.Liking for brown rice,36100,-0.113415001109489,0.0384516077104204,-0.188780152221913,-0.0380498499970654,0.00319304405651423
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20625.Liking for brussel sprouts,36100,-0.101848735660441,0.0393027598443591,-0.178882144955385,-0.0248153263654973,0.009579081259804
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20626.Liking for burgers (meat),36100,0.0103029596431752,0.0384581238630732,-0.0650749631284482,0.0856808824147986,0.788783739345092
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36100,0.020262212094993,0.0381268964328998,-0.0544665049134907,0.0949909291034767,0.595130037853855
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20628.Liking for butter on bread,36100,0.07008758222756,0.039031746048252,-0.00641464002701382,0.146589804482134,0.0725930280966915
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20629.Liking for butternut squash,36100,-0.101922542234174,0.0382459068287947,-0.176884519618611,-0.0269605648497364,0.00771843756058939
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20630.Liking for cabbage,36100,-0.0712855504577033,0.0389332867898292,-0.147594792565768,0.00502369165036184,0.0671486370863418
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20631.Liking for cake,36100,0.0326194206619654,0.0380292525771542,-0.0419179143892569,0.107156755713188,0.391062808628718
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20632.Liking for cake icing,36100,0.0157221321491312,0.0382409232476896,-0.0592300774163404,0.0906743417146028,0.680987276134719
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20633.Liking for capers,36100,-0.0207513161899633,0.0379436247549763,-0.0951208207097168,0.0536181883297902,0.584466074071474
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20634.Liking for cauliflower,36100,-0.039782478582797,0.0394015984078612,-0.117009611462205,0.037444654296611,0.312690460951999
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36100,0.0245160323475546,0.0376927370861568,-0.0493617323413127,0.098393797036422,0.515443958084222
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20636.Liking for cheesecake,36100,0.0377512496537895,0.0383421649296204,-0.0373993936082665,0.112901892915846,0.324860842293188
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20637.Liking for cherries,36100,-0.123113208653309,0.0407679911692338,-0.203018471345007,-0.0432079459616108,0.00253825896216351
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20638.Liking for chicken,36100,-0.0941247242929645,0.0401788687393415,-0.172875307022074,-0.0153741415638552,0.0191759993723049
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20639.Liking for chilli pepper,36100,0.0117252416512344,0.0382315872007724,-0.0632086692622795,0.0866591525647484,0.759088676477608
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20640.Liking for chips or french fries,36100,0.0774236680150626,0.0385305297145437,0.001903829774557,0.152943506255568,0.0445324548991669
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20641.Liking for cigarette smoking,36100,0.271111540717284,0.0656254312519355,0.14248569546349,0.399737385971077,3.6514626030836e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20642.Liking for cod,36100,-0.0303762745785262,0.0397358523529926,-0.108258545190392,0.0475059960333394,0.444622243126747
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20643.Liking for coffee with sugar,36100,0.144878706962579,0.0413182608854674,0.0638949156270629,0.225862498298095,0.000457086955283959
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20644.Liking for coffee without sugar,36100,-0.0923417056299306,0.0395090950524083,-0.169779531932651,-0.0149038793272104,0.0194558678540802
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20645.Liking for coriander,36100,-0.0943994008824737,0.0382489374962825,-0.169367318375187,-0.0194314833897599,0.0136101019261884
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20646.Liking for corn flakes,36100,0.0206723587935984,0.0384530655396442,-0.0546956496641043,0.0960403672513011,0.590870740911817
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20647.Liking for cream,36100,0.0721987837675617,0.0384667829919669,-0.00319611089669335,0.147593678431817,0.0605722758939047
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20648.Liking for croissant,36100,0.0224498100835021,0.0380582122959245,-0.0521442860165099,0.0970439061835142,0.555289866818161
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20649.Liking for cucumber,36100,-0.138952072698725,0.0389057876977758,-0.215207416586365,-0.0626967288110839,0.000357359872462801
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20650.Liking for curry,36100,-0.0412756693723939,0.0387793303706934,-0.117283156898953,0.0347318181541652,0.28719705475389
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20651.Liking for dairy products,36100,-0.0019632431194125,0.0385864761359496,-0.0775927363458737,0.0736662501070487,0.959423375600342
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20652.Liking for dark chocolate,36100,0.035899997550663,0.0389118918993866,-0.0403673105721347,0.112167305673461,0.356249494510328
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36100,0.0360389987483524,0.0396650535076231,-0.041704506126589,0.113782503623294,0.363601957664101
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20654.Liking for dried fruit,36100,-0.0641282620753539,0.0391952265293002,-0.140950906072782,0.0126943819220745,0.101859205885331
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20655.Liking for eggs,36100,0.0399313800678853,0.0399836282981261,-0.0384365313964418,0.118299291532212,0.31797834331292
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20656.Liking for exercising alone,36100,-0.0704155196623259,0.0379715161663339,-0.14483969134834,0.00400865202368854,0.0637203174137508
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20657.Liking for exercising with others,36100,0.00590191618598742,0.0379555492362164,-0.0684909603169968,0.0802947926889716,0.876435270844865
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36100,-0.078509940320012,0.0388306668792557,-0.154618047403353,-0.00240183323667092,0.0432299700063179
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20659.Liking for fatty foods,36100,0.0607178241459285,0.0387359978791974,-0.0152047316972984,0.136640379989155,0.117048882184988
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36100,-0.112290503990276,0.0412957177982563,-0.193230110874858,-0.0313508971056936,0.00656077099553902
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20661.Liking for fried chicken,36100,0.0719345220928727,0.0376867082633644,-0.00193142610332155,0.145800470289067,0.056335753689735
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20662.Liking for fried or battered fish,36100,0.102207063072937,0.038722984166459,0.0263100141066776,0.178104112039197,0.00832295023435652
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20663.Liking for fruit,36100,-0.145994687061598,0.04360386021447,-0.23145825308196,-0.0605311210412373,0.000817723169473954
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20664.Liking for garlic,36100,-0.104362534270352,0.0386758029771076,-0.180167108105482,-0.0285579604352207,0.00698446788980476
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20665.Liking for gherkins,36100,0.00954270042658156,0.0384042059082946,-0.0657295431536759,0.084814944006839,0.803769970434556
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20666.Liking for globe artichoke,36100,-0.0524093736110633,0.0380563874121375,-0.126999892938853,0.0221811457167263,0.168510409545545
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20667.Liking for goat's cheese,36100,-0.0346336360947374,0.0383430600838958,-0.109786033859173,0.0405187616696984,0.366421076207081
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20668.Liking for going to a cafe,36100,-0.0104540343824648,0.038168679530139,-0.0852646462615372,0.0643565774966076,0.784177061675379
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20669.Liking for going to the gym,36100,-0.0523627863552353,0.0379537168153714,-0.126752071313363,0.0220264986028926,0.167739639867663
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20670.Liking for going to the pub,36100,0.0288260108227473,0.0384689336790294,-0.0465730991881504,0.104225120833645,0.453682558925523
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20671.Liking for grapefruit,36100,-0.0568545278461003,0.0383123535223466,-0.1319467407499,0.018237685057699,0.137861574676538
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20672.Liking for green olives,36100,-0.0256823923066337,0.0386852002641952,-0.101505384824456,0.0501406002111889,0.506788290436287
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20673.Liking for haddock,36100,-0.027614947551569,0.0396824708784705,-0.105392590473371,0.0501626953702332,0.486516230169732
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20674.Liking for ham,36100,0.0117238828289852,0.0386090077164321,-0.0639497722952217,0.0873975379531921,0.761398629754226
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20675.Liking for hard cheese,36100,0.0528421487717217,0.0394224456117622,-0.0244258446273322,0.130110142170776,0.180156991780184
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20676.Liking for herring,36100,-0.0557280487138416,0.0382357929902989,-0.130670202974827,0.0192141055471442,0.145028409188129
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20677.Liking for honey,36100,-0.0702929548929978,0.0389630765692303,-0.146660584968689,0.00607467518269347,0.0712605767731457
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36100,-0.0473711488984302,0.0382483854591175,-0.1223379843983,0.02759568660144,0.215567801452127
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20679.Liking for ice cream,36100,0.0145017866111059,0.03876781434222,-0.0614831294996453,0.0904867027218572,0.708365457850552
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20680.Liking for jam,36100,0.0661587975246137,0.0384336776058359,-0.00917121058282469,0.141488805632052,0.0852275196047524
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20681.Liking for kiwi fruit,36100,-0.110922942485975,0.0380345481549852,-0.185470656869746,-0.0363752281022042,0.00355268016348311
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20682.Liking for lager,36100,0.0265172965178639,0.038821814272381,-0.0495734594560029,0.102608052491731,0.494597275380498
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20683.Liking for lamb,36100,-0.0245400193226937,0.038934887195858,-0.100852398226575,0.051772359581188,0.528529958250055
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20684.Liking for lemons,36100,-0.0490327020394619,0.0385571820204918,-0.124604778799626,0.0265393747207021,0.203526909139865
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20685.Liking for lentils or beans,36100,-0.0451685329600856,0.0386299518228562,-0.120883238532884,0.0305461726127126,0.242338514654163
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20686.Liking for liver,36100,-0.0119040758743739,0.0386769834823928,-0.0877109634998638,0.063902811751116,0.758257580825219
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20687.Liking for mackerel,36100,-0.0751795611051208,0.0385838961081814,-0.150803997477156,0.000444875266914876,0.0513992603525332
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20688.Liking for marzipan,36100,-0.0172514746864467,0.0384290787743041,-0.0925724690840828,0.0580695197111894,0.653505487494983
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20689.Liking for mayonnaise,36100,-0.0446942359526483,0.0386173243671156,-0.120384191712195,0.0309957198068984,0.247164443543901
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20690.Liking for melon,36100,-0.0815938903312913,0.0399273756261762,-0.159851546558597,-0.00333623410398606,0.0410351907415405
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20691.Liking for milk chocolate,36100,0.0319623674614537,0.0385227377039088,-0.0435421984382076,0.107466933361115,0.406736373945573
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20692.Liking for mushrooms,36100,-0.108873217927493,0.0396693295095977,-0.186625103766305,-0.0311213320886816,0.00607565079984983
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20694.Liking for orange juice,36100,0.0115446800182594,0.0386699392234203,-0.0642484008596443,0.0873377608961632,0.765296959767439
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20695.Liking for oranges,36100,-0.130381605183287,0.0391003150360669,-0.207018222653978,-0.0537449877125956,0.000858910303698512
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20696.Liking for pasta,36100,-0.0575725652556901,0.0386390539199899,-0.13330511093887,0.0181599804274902,0.136267411860441
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20697.Liking for pears,36100,-0.0653342683334339,0.0390284913125379,-0.141830111306008,0.0111615746391403,0.0941730522402915
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20698.Liking for pizza,36100,0.0184960584506886,0.0379770046175379,-0.0559388705996857,0.0929309875010629,0.626250348886161
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20699.Liking for plain yogurt,36100,-0.0992098784835647,0.0389147907230402,-0.175482868300723,-0.0229368886664059,0.0108118932774683
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20700.Liking for plums,36100,-0.0934992943494584,0.0396100960343901,-0.171135082576863,-0.0158635061220538,0.0182784128778588
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20701.Liking for pollock,36100,-0.013614768869705,0.0380842290484177,-0.0882598578046037,0.0610303200651937,0.720735206163357
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20702.Liking for pork chop,36100,-0.0487232120471338,0.0382821313299744,-0.123756189453884,0.0263097653596159,0.203153106724548
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20703.Liking for porridge,36100,-0.0712327984875791,0.0389275352962406,-0.147530767668211,0.0050651706930524,0.0673107162893369
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20704.Liking for potato crisps,36100,0.078489015579324,0.0383786255777946,0.00326690944684664,0.153711121711801,0.0408805884794869
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20705.Liking for potatoes,36100,0.00496230053058243,0.0386369027974244,-0.0707660289523695,0.0806906300135343,0.897809094743768
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20706.Liking for prawns,36100,-0.0671727308273869,0.0389659097028226,-0.143545913844919,0.00920045219014544,0.0847734943037829
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20707.Liking for raw carrots,36100,-0.0651597559483271,0.0385952059942834,-0.140806359697122,0.0104868478004683,0.0914015002848483
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20708.Liking for red meat,36100,-0.0193986746510825,0.0385094586432772,-0.0948772135919058,0.0560798642897407,0.614461645385406
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20709.Liking for red wine,36100,-0.0680101202439234,0.0390864040594639,-0.144619472200473,0.00859923171262582,0.0819046237800331
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36100,0.1347186687264,0.0392873219936301,0.0577155176188853,0.211721819833915,0.000609216227219375
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20711.Liking for roast chicken,36100,-0.054626838413563,0.0399794793104467,-0.132986617862038,0.0237329410349125,0.171866797647441
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20712.Liking for salad dressing,36100,-0.0111206725435846,0.0384401214286054,-0.0864633105436511,0.064221965456482,0.772361594310554
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20713.Liking for salad leaves,36100,-0.0566839012128588,0.0391259348900672,-0.13337073359739,0.020002931171673,0.147451422853246
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20714.Liking for salami,36100,0.00104395627085047,0.0385005238492151,-0.0744170704736111,0.0765049830153121,0.978368493610556
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20715.Liking for salmon,36100,-0.0903006415789993,0.0405400245287695,-0.169759089655388,-0.0108421935026111,0.025949745099011
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20716.Liking for salty foods,36100,0.0656499865740467,0.0381091507222349,-0.00904394884153374,0.140343921989627,0.0849906912020229
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20717.Liking for salty pretzels,36100,-0.0353131692678754,0.0382111769507092,-0.110207076091265,0.0395807375555146,0.355436330285562
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20718.Liking for sardines,36100,-0.0214432288359189,0.0386514885954286,-0.097200146482959,0.0543136888111212,0.579060377962666
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20719.Liking for sausages (meat),36100,0.0240992084207933,0.0387096823899208,-0.0517717690634515,0.0999701859050381,0.533592442486111
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20720.Liking for savoury biscuits,36100,0.0109159603274215,0.0384597059603122,-0.0644650633547903,0.0862969840096333,0.776550338625531
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36100,-0.0720561240984537,0.0383117835723712,-0.147147219900301,0.00303497170339381,0.0600436369190754
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20722.Liking for skimmed milk,36100,-0.034341790991942,0.0383535565956869,-0.109514761919488,0.0408311799356043,0.370604319717269
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20723.Liking for smoked fish,36100,-0.0177984866232279,0.0388559671537802,-0.0939561822446371,0.0583592089981812,0.646921505020881
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20724.Liking for soft cheese,36100,-0.0193915583650834,0.0387558450325715,-0.0953530146289236,0.0565698978987567,0.616843322533263
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20725.Liking for soy sauce,36100,-0.0112003688284413,0.0380856628734005,-0.0858482680603063,0.0634475304034237,0.768702872382834
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20726.Liking for soya milk,36100,-0.0577397127923837,0.0385887541904634,-0.133373671005692,0.0178942454209245,0.134625572155081
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20727.Liking for spicy foods,36100,-0.00865519002334099,0.0385914961072055,-0.0842945223934639,0.0669841423467819,0.822548313246121
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20728.Liking for spinach,36100,-0.113161190461291,0.0385590775543954,-0.188736982467906,-0.0375853984546765,0.00334919224866939
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20729.Liking for spirits,36100,-0.0523491421231941,0.0382821817760991,-0.127382218404348,0.0226839341579601,0.171527445774818
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20730.Liking for strawberries,36100,-0.0801443274365124,0.0419448080625352,-0.162356151239081,0.00206749636605666,0.056083390537232
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36100,0.106755898001458,0.0391444769299926,0.0300327232186726,0.183479072784243,0.00640305251210281
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20732.Liking for sweet foods,36100,0.0489986973208293,0.0385234035630156,-0.0265071736626814,0.12450456830434,0.203444338452501
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20733.Liking for taking the stairs,36100,-0.0802442492643974,0.0393508388731327,-0.157371893455738,-0.00311660507305733,0.0414680648491725
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20734.Liking for tea with sugar,36100,0.132933163654003,0.0461630305635533,0.0424536237494389,0.223412703558568,0.00399348156329659
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20735.Liking for tea without sugar,36100,-0.0225828108131032,0.0403370345078278,-0.101643398448446,0.0564777768222393,0.575597873360096
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20736.Liking for tomato ketchup,36100,0.0604378829029006,0.0384237240825678,-0.0148726162989323,0.135748382104734,0.115780567473127
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20737.Liking for tinned tuna,36100,-0.0492193672172512,0.0385975481073782,-0.124870561507713,0.0264318270732102,0.202283486762615
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20738.Liking for turnip (white),36100,-0.0433855717762742,0.0384866569245313,-0.118819419348356,0.0320482757958072,0.259659673189052
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20739.Liking for vegetables,36100,-0.17159717156784,0.0422593193138294,-0.254425437422946,-0.0887689057127344,4.94936925034418e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20740.Liking for vinegar,36100,0.0446386066024401,0.0382689992375693,-0.0303686319031956,0.119645845108076,0.243475709226601
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20741.Liking for watching television,36100,0.0985448602082543,0.0387691682558676,0.0225572904267538,0.174532429989755,0.0110488909165023
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20742.Liking for whisky,36100,-0.00738901280487547,0.0394730665788743,-0.0847562232994691,0.0699781976897182,0.851516188596414
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20743.Liking for white bread,36100,0.105308926369623,0.0377549505908755,0.0313092232115068,0.179308629527739,0.00529711482067806
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20744.Liking for white rice,36100,-0.0166905474075871,0.0381057564900188,-0.091377830128024,0.0579967353128497,0.661395699667906
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20745.Liking for white wine,36100,-0.0710378521383238,0.0385284047744083,-0.146553525496164,0.00447782121951643,0.065258267270211
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36100,-0.142115484558174,0.0388829614820585,-0.218326089063009,-0.0659048800533397,0.000259138787822676
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20747.Liking for whole milk,36100,0.0781143449951672,0.0382280684427392,0.00318733084739838,0.153041359142936,0.0410530809589258
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20748.Liking for wholemeal bread,36100,-0.0843010286928057,0.0402571845098841,-0.163205110332179,-0.00539694705343276,0.0362908946556375
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20749.Liking for working up a sweat,36100,0.00754130785951735,0.0384319299666744,-0.0677852748751644,0.0828678905941991,0.844439793472299
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21001.Body mass index (BMI),51733,0.0416800918890804,0.0182641903751575,0.00588227875377161,0.0774779050243891,0.022494707275953
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21002.Weight,51752,0.00102149653827277,0.00978772830925278,-0.0181624509478627,0.0202054440244082,0.91688060260055
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36896,-0.00155887300785765,0.00654422000044823,-0.0143855442087362,0.0112677981930209,0.811727596705827
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35928,-0.0143196697662118,0.0422073804093667,-0.0970461353685706,0.068406795836147,0.734417430699294
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35945,0.0938447208025859,0.0424118541471857,0.0107174866741019,0.17697195493107,0.0269516674128959
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35947,0.000355016262158127,0.0417836559368726,-0.0815409493741122,0.0822509818984285,0.993221079186084
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21040.Satisfaction with bowel habits,35901,-0.00128348472864788,0.0388551947548739,-0.0774396664482008,0.074872696990905,0.973649644349133
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35882,-0.000674761499989524,0.0419297989534905,-0.0828571674488309,0.0815076444488518,0.987160959380101
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21042.Greatest number of times bowels opened per day,35902,-0.0441853424540053,0.0410121436792244,-0.124569144065285,0.0361984591572746,0.281352777826346
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21043.Least number of times bowels opened per week,35837,-0.00561772565920583,0.041761155645502,-0.0874695907243897,0.0762341394059781,0.892995188935335
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21044.Average number of times bowels opened per day,35866,0.012166406531285,0.0466477850363496,-0.0792632521399602,0.10359606520253,0.794243822593097
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35951,-0.0190892909592173,0.042055008911144,-0.10151710842506,0.0633385265066251,0.649906442840927
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35946,0.0250901509641664,0.0422053940571423,-0.0576324213878325,0.107812723316165,0.552212806314427
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32736,0.0697901578025855,0.075842343353612,-0.0788608351704941,0.218441150775665,0.357530706458167
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35949,-0.0529388565663826,0.0479325498227499,-0.146886654218972,0.0410089410862072,0.269439570107307
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35948,-0.0737899497674033,0.0617767674697991,-0.194872414008209,0.047292514473403,0.232339573965767
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35946,-0.0735624989267433,0.0478484672428224,-0.167345494722675,0.0202204968691886,0.124240893372123
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35946,0.187847342974205,0.125012109560628,-0.0571763917646252,0.432871077713036,0.132980436589429
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35952,-0.0605196949801308,0.0488250189409408,-0.156216732104375,0.0351773421441131,0.215195220133086
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35949,-0.234153166348969,0.0451381381363718,-0.322623917096258,-0.145682415601681,2.19364167407006e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35796,0.0365841299776989,0.0437979301793789,-0.0492598131738837,0.122428073129282,0.403582665805715
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35942,0.0237476156051294,0.0417616804147696,-0.0581052780078191,0.105600509218078,0.569615276930971
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35948,-0.0939509697113706,0.065520918415398,-0.222371969805551,0.0344700303828096,0.151644815932077
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35953,-0.0699553394336616,0.0421441483874782,-0.152557870273119,0.0126471914057956,0.0969796902297387
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35952,0.0154537310204745,0.0418453224523321,-0.0665631009860964,0.0974705630270454,0.711911183808096
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X21100.Water hardness (USGS classification),51698,-0.0405392668331149,0.0216115963194305,-0.0828979956191988,0.00181946195296895,0.0606941935899485
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2139.Age first had sexual intercourse,47976,-0.0137415079823056,0.00443520320173019,-0.0224345062576968,-0.00504850970691446,0.00194933690296657
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2149.Lifetime number of sexual partners,46792,0.0405497725347506,0.0249049479450878,-0.00826392543762146,0.0893634705071226,0.103504333447636
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22032.IPAQ activity group,46823,-0.0521755739736827,0.0247231164622528,-0.100632882239698,-0.00371826570766724,0.0348382818685333
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22033.Summed days activity,47317,-0.0114747775444615,0.00436766297009441,-0.0200353969658465,-0.00291415812307643,0.00861600964042694
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22034.Summed minutes activity,46823,-0.00861648912848634,0.00432300020159048,-0.0170895695236037,-0.000143408733369004,0.0462578461079625
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22037.MET minutes per week for walking,45863,-0.000961261791745166,0.00464478830874596,-0.0100650468768872,0.00814252329339691,0.836047592949517
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22038.MET minutes per week for moderate activity,46823,-0.00626138817160843,0.00422101339215619,-0.0145345744202346,0.00201179807701771,0.137990013423001
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22039.MET minutes per week for vigorous activity,46823,-0.0821973569818137,0.0250028075991069,-0.131202859876063,-0.0331918540875641,0.00101269920508019
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22040.Summed MET minutes per week for all activity,45863,-0.00789586663318508,0.00450863933430348,-0.0167327997284199,0.000941066462049747,0.0799169705939932
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X2217.Age started wearing glasses or contact lenses,49907,0.00497757256506851,0.00367197734421414,-0.00221950302959121,0.0121746481597282,0.175255116949873
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X22501.Year ended full time education,34036,-0.0191834498674912,0.0181799400593318,-0.0548161323837815,0.016449232648799,0.291387086983656
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X22506.Tobacco smoking,34005,-0.170536343483215,0.0930709528462187,-0.352955411061803,0.0118827240953738,0.0669646428211012
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50545,-0.115820795884223,0.0831056476535842,-0.278707865285248,0.0470662735168017,0.163435610450411
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23098.Weight,51269,0.00277594757992441,0.00988344374211893,-0.0165956021546287,0.0221474973144775,0.778813928145965
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23099.Body fat percentage,51263,0.0499483633381105,0.00938838464902416,0.0315471294260232,0.0683495972501979,1.04646451440981e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23100.Whole body fat mass,51250,0.0428359379806464,0.00925193429916631,0.0247021467542804,0.0609697292070124,3.67849025046459e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23101.Whole body fat-free mass,51268,-0.0193561772112639,0.0080600511012569,-0.0351538773697274,-0.00355847705280035,0.0163364205123157
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23102.Whole body water mass,51269,-0.0183561494442312,0.00808393708369353,-0.0342006661282705,-0.00251163276019186,0.0231750839805015
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23104.Body mass index (BMI),51269,0.0431946409733842,0.0182633450590414,0.007398484657663,0.0789907972891053,0.0180337903583462
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23105.Basal metabolic rate,51269,-0.0172423613957835,0.00860708491164311,-0.034112247822604,-0.000372474968962998,0.0451599384961621
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23106.Impedance of whole body,51267,0.0297828062627138,0.00656516190938442,0.0169150889203203,0.0426505236051072,5.74987627678425e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23107.Impedance of leg (right),51269,0.0281435738887544,0.00530982228468595,0.0177363222107699,0.0385508255667388,1.16732102103558e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23108.Impedance of leg (left),51269,0.0262607602508201,0.00527525021690479,0.0159212698256867,0.0366002506759535,6.46926696579634e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23109.Impedance of arm (right),51266,0.0158757616574684,0.00647810322299955,0.00317867934038926,0.0285728439745475,0.0142663461138783
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23110.Impedance of arm (left),51269,0.018847016675803,0.00650645109450042,0.00609437253058219,0.0315996608210238,0.00377521264346332
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23111.Leg fat percentage (right),51269,0.0561885654364503,0.011070729944316,0.0344899347455909,0.0778871961273098,3.89786305760516e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23112.Leg fat mass (right),51269,0.0567259731866857,0.0121241721106815,0.03296259584975,0.0804893505236215,2.90339821254838e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23113.Leg fat-free mass (right),51268,-0.0233584873154235,0.00819732009471475,-0.0394252347010644,-0.00729173992978255,0.0043824768780325
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23114.Leg predicted mass (right),51268,-0.0228617518434603,0.00824754707449458,-0.0390269441094696,-0.00669655957745089,0.0055769022400424
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23115.Leg fat percentage (left),51266,0.0538745609918712,0.0116386494647632,0.0310628080409352,0.0766863139428071,3.69641053460408e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23116.Leg fat mass (left),51266,0.0570277011176577,0.0126882554973044,0.0321587203429411,0.0818966818923743,7.00792090549735e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23117.Leg fat-free mass (left),51265,-0.0195903108769763,0.00863134324388099,-0.0365077436349831,-0.0026728781189696,0.0232371452085554
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23118.Leg predicted mass (left),51265,-0.0200878239829801,0.00868549321469076,-0.037111390683774,-0.00306425728218624,0.020742690670217
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23119.Arm fat percentage (right),51265,0.0371005139704919,0.0106058576368523,0.0163130330022613,0.0578879949387224,0.000469480393146849
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23120.Arm fat mass (right),51263,0.0276125258582484,0.0105783109708792,0.00687903635532516,0.0483460153611717,0.00905249469092315
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23121.Arm fat-free mass (right),51264,-0.0135332838843952,0.00823013317288682,-0.0296643449032533,0.00259777713446301,0.100116553878067
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23122.Arm predicted mass (right),51264,-0.0151469360924914,0.00824680180442363,-0.0313106676291617,0.00101679544417891,0.066267004663085
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23123.Arm fat percentage (left),51263,0.0411733963440745,0.0108561229897195,0.0198953952842242,0.0624513974039247,0.000149449724841538
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23124.Arm fat mass (left),51263,0.0312729676835369,0.0105898528963542,0.0105168560066827,0.0520290793603911,0.00314924504576909
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23125.Arm fat-free mass (left),51263,-0.0160183632594735,0.00839963559981174,-0.0324816490351045,0.000444922516157492,0.0565295781272075
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23126.Arm predicted mass (left),51261,-0.0158962560567196,0.00840183653235551,-0.0323638556601364,0.00057134354669721,0.0585043560040932
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23127.Trunk fat percentage,51260,0.031636549202698,0.00671695168203325,0.0184713239059128,0.0448017744994832,2.49277368985682e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23128.Trunk fat mass,51260,0.0312578818157816,0.0075150040542619,0.0165284738694283,0.045987289762135,3.20295881404711e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23129.Trunk fat-free mass,51259,-0.015661211005063,0.00728140837520138,-0.0299327714204577,-0.00138965058966825,0.0314989341102543
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23130.Trunk predicted mass,51256,-0.0167198364814669,0.00730199362822912,-0.031031743992796,-0.00240792897013786,0.0220444420049898
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23400.Total Cholesterol,42346,0.0208799629953888,0.00515321972286914,0.0107796523385653,0.0309802736522123,5.11109292980007e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42346,0.0320631877989071,0.0049966942600522,0.0222696670492047,0.0418567085486094,1.43864065484366e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42346,0.037895671048582,0.00498630450227605,0.0281225142241209,0.047668827873043,3.1626552262865e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23403.VLDL Cholesterol,42346,0.0489738578125686,0.00506499297072299,0.0390464715899516,0.0589012440351857,4.83068223954549e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42346,0.0251702603002826,0.0049956958068243,0.015378696518907,0.0349618240816583,4.75695957320288e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23405.LDL Cholesterol,42346,0.0258538071696913,0.00502132617779394,0.0160120078612152,0.0356956064781675,2.65942047784258e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23406.HDL Cholesterol,42346,-0.0358100851326267,0.00574988280397991,-0.0470798554284274,-0.0245403148368261,4.86913800594702e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23407.Total Triglycerides,42346,0.0403821367560858,0.00548911837399089,0.0296234647430636,0.0511408087691079,1.9958979443825e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23408.Triglycerides in VLDL,42346,0.038582166337224,0.0054670253915736,0.0278667965697398,0.0492975361047083,1.78341702149046e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23409.Triglycerides in LDL,42346,0.0426380988343381,0.00544751704318436,0.0319609654296968,0.0533152322389795,5.37417437980253e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23410.Triglycerides in HDL,42346,0.030622488725553,0.00538657152315048,0.0200648085401781,0.0411801689109279,1.33618050892949e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42346,0.0168921657123751,0.00534307812056577,0.00641973259606614,0.027364598828684,0.00157312703373899
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23412.Phospholipids in VLDL,42346,0.0494072980761577,0.00523197698965777,0.0391526231764284,0.0596619729758869,4.21164435603038e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23413.Phospholipids in LDL,42346,0.0269350463365261,0.00499073874558854,0.0171531983951725,0.0367168942778796,6.89373953525601e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23414.Phospholipids in HDL,42346,-0.0292804074958205,0.00571356105213802,-0.040478987158011,-0.0180818278336299,3.02202414198075e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23415.Total Esterified Cholesterol,42346,0.0176303766125116,0.00517929940068194,0.00747894978717504,0.0277818034378483,0.000666029910474853
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42346,0.0477741890339135,0.00500477657532611,0.0379648269462744,0.0575835511215527,1.58705362912574e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42346,0.0278740849818732,0.00502722973145966,0.0180207147082122,0.0377274552555341,3.00268765673471e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42346,-0.0389231832239887,0.00571915224940671,-0.0501327216328259,-0.0277136448151516,1.04872834224089e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23419.Total Free Cholesterol,42346,0.0285336753866734,0.00509269712023592,0.018551989031011,0.0385153617423359,2.15075319784285e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42346,0.0493917867045586,0.00516960678175176,0.0392593574123251,0.059524215996792,1.46223405620176e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23421.Free Cholesterol in LDL,42346,0.0197161485015182,0.00502985336974848,0.00985763589681119,0.0295746611062252,8.90621571055533e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23422.Free Cholesterol in HDL,42346,-0.0229261546798848,0.00581375492091737,-0.0343211143248828,-0.0115311950348868,8.07398133732688e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42346,0.028224443017601,0.00514403819081239,0.0181421281636088,0.0383067578715933,4.1678974537579e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23424.Total Lipids in VLDL,42346,0.0463159304908363,0.00530616371271113,0.0359158496139225,0.0567160113677501,2.8836597677043e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23425.Total Lipids in LDL,42346,0.0277825157224338,0.0050172450057643,0.0179487155111358,0.0376163159337319,3.12873266059197e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23426.Total Lipids in HDL,42346,-0.0299495228553815,0.00574468218068693,-0.0412090999295279,-0.0186899457812351,1.88185523907567e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42346,-0.0164439271067686,0.00542455487394042,-0.0270760546596918,-0.00581179955384536,0.00243906387164517
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23428.Concentration of VLDL Particles,42346,0.049918278195094,0.00516142702840463,0.0398018812194209,0.060034675170767,4.72301147955499e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23429.Concentration of LDL Particles,42346,0.03816659425841,0.00497018035751596,0.0284250407576788,0.0479081477591413,1.71482125670842e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23430.Concentration of HDL Particles,42346,-0.0249572488251932,0.00543181324184993,-0.0356036027792191,-0.0143108948711674,4.37517046755544e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42346,0.0250218494752513,0.0055669403561271,0.0141106463772422,0.0359330525732604,7.0255817740068e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42346,-0.0020518709347617,0.00531342746068871,-0.0124661887577116,0.00836244688818817,0.699379155960987
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42346,-0.0237113091027583,0.00595677406380299,-0.0353865862678122,-0.0120360319377045,6.91218625174558e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23434.Phosphoglycerides,42335,0.00707684319260313,0.00544820160433465,-0.00360163195189279,0.017755318337099,0.19399007077751
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42335,0.0433198192420117,0.00570060577244574,0.0321466319280181,0.0544930065560054,3.18212218552468e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23436.Total Cholines,42335,0.00752273195569461,0.00545336803389492,-0.00316586939073944,0.0182113333021287,0.167774812090936
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23437.Phosphatidylcholines,42335,0.0050618060993828,0.00549705291344716,-0.00571241761097363,0.0158360298097392,0.357160380619305
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23438.Sphingomyelins,42335,0.0119240080131382,0.00535265776239281,0.00143279879884832,0.0224152172274281,0.0259187338589389
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23439.Apolipoprotein B,42346,0.0388746608940304,0.00496655067165544,0.0291402215775858,0.0486091002104751,5.36459445379664e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23440.Apolipoprotein A1,42346,-0.0283939479807674,0.00560737496076997,-0.0393844029038766,-0.0174034930576583,4.16805997818659e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42346,0.0487841808310699,0.00508051576214142,0.0388263699372727,0.058741991724867,9.22226683270298e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23442.Total Fatty Acids,42335,0.0289390734030861,0.00530022071049462,0.0185506408105166,0.0393275059956556,4.84850355936776e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23443.Degree of Unsaturation,42335,-0.0362698155492787,0.00538760153276083,-0.0468295145534899,-0.0257101165450675,1.74189546481346e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42335,-0.00775483788793725,0.00535919318618549,-0.0182588565328608,0.00274918075698631,0.147916316275122
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42335,0.020768867329667,0.00521985671120804,0.0105379481756992,0.0309997864836347,6.96300887104441e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42335,0.0165421988709716,0.00529800263162805,0.0061581137129806,0.0269262840289626,0.00179805158687308
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42335,0.0367719736331338,0.00542876171262269,0.0261316006763933,0.0474123465898742,1.3101100602988e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23448.Saturated Fatty Acids,42335,0.0293657046343,0.00530166901499758,0.0189744333649047,0.0397569759036953,3.10128261793119e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23449.Linoleic Acid,42335,0.0252932157038366,0.00511124447569186,0.0152751765314805,0.0353112548761926,7.5697050269863e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23450.Docosahexaenoic Acid,42335,-0.0170517257702287,0.00534778561836207,-0.0275333855822184,-0.00657006595823904,0.0014331945616012
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42335,-0.0264890504640143,0.0052886767862327,-0.0368548569650304,-0.0161232439629982,5.55290223072511e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42335,-0.0267029427243778,0.00569906175991202,-0.0378731037738054,-0.0155327816749502,2.82081086548684e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42335,-0.0373961645490881,0.00561640233656635,-0.0484043131287582,-0.0263880159694181,2.87858235867205e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42335,0.0404674233263586,0.00568501307082795,0.0293247977075358,0.0516100489451814,1.14970603478527e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42335,0.0157106644268053,0.00516275396773345,0.00559166665004773,0.0258296622035629,0.00234633906843035
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42335,-0.00150687075119627,0.00546977276359424,-0.012227625367841,0.00921388386544844,0.78294371039937
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42335,-0.0345075061328191,0.00526663093276153,-0.0448301027610317,-0.0241849095046065,5.88474468600204e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42335,-0.041429104634939,0.00569815039896442,-0.0525974794169093,-0.0302607298529687,3.78068679711291e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42335,0.0178519977353342,0.00523717521708812,0.00758713430984148,0.0281168611608269,0.000654674238528045
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23460.Alanine,42341,0.00298888751748352,0.00516729930418325,-0.00713901911871566,0.0131167941536827,0.562988117884899
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23461.Glutamine,42303,-0.00367227449770731,0.00518341678446549,-0.0138317713952597,0.00648722239984505,0.478668523280642
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23462.Glycine,42330,0.00591344187372629,0.0055064491186719,-0.00487919839887063,0.0167060821463232,0.282881843639157
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23463.Histidine,42327,-0.00636463069600495,0.00509007440654763,-0.0163411765328383,0.00361191514082841,0.211175623849892
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42337,-0.00997712522728258,0.00539626674219424,-0.0205538080419833,0.000599557587418125,0.0644955620658998
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23465.Isoleucine,42342,-0.00964297868195241,0.00525039427454658,-0.0199337514600637,0.000647794096158892,0.0662885867812473
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23466.Leucine,42342,-0.0117031914523851,0.00531007953059272,-0.0221109473323469,-0.00129543557242337,0.0275445745649876
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23467.Valine,42337,-0.00827207746882015,0.00545633012686826,-0.0189664845174819,0.00242232957984163,0.129530380237481
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23468.Phenylalanine,42339,-0.00273557178317304,0.00515138117182682,-0.0128322788799536,0.00736113531360752,0.59540241030178
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23469.Tyrosine,42330,0.00176368518774961,0.00524337421997553,-0.00851332828340243,0.0120406986589016,0.736601354695241
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23470.Glucose,42319,-0.00579814546419244,0.00509044459213709,-0.0157754168647811,0.00417912593639626,0.254713366708789
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23471.Lactate,42321,0.0101785051024728,0.00511547450066745,0.000152175081164633,0.020204835123781,0.0466394154522815
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23472.Pyruvate,42306,0.0114615841758178,0.00516398558732102,0.00134017242466864,0.021582995926967,0.026468215866611
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23473.Citrate,42343,0.01471439646719,0.00517144163901109,0.00457837085472823,0.0248504220796517,0.00444356629477694
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23474.3-Hydroxybutyrate,42130,0.000164159972899378,0.00542428156022296,-0.0104674318851376,0.0107957518309364,0.975857045321756
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23475.Acetate,42335,-0.0144501144136545,0.0050886804582944,-0.0244239281119115,-0.00447630071539748,0.00452312012195778
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23476.Acetoacetate,42344,-0.00374856300439296,0.00522001336345806,-0.0139797891967708,0.00648266318798484,0.472699953740695
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23477.Acetone,42344,-0.0189806205421022,0.00517115810259195,-0.0291160904231824,-0.00884515066102199,0.000243055420722602
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23478.Creatinine,42039,0.0387228471993166,0.00579508063104963,0.0273644891624593,0.0500812052361739,2.45393359415288e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23479.Albumin,42344,-0.0194691643021797,0.00517757350722622,-0.0296172083763431,-0.00932112022801629,0.000170453670933851
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23480.Glycoprotein Acetyls,42346,0.0413080199703419,0.00547064925412027,0.0305855474322662,0.0520304925084177,4.60916767767712e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42346,0.0402664084229035,0.00550694288476774,0.0294728003687588,0.0510600164770483,2.78544915659335e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42346,0.0369373490239082,0.00544477670761069,0.0262655866769912,0.0476091113708251,1.21897515986768e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42346,0.0398272994785485,0.00552063496017415,0.0290068549566072,0.0506477440004899,5.7197242801786e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42346,0.0422647187954601,0.00546509118086262,0.0315531400809694,0.0529762975099509,1.1215002530623e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42346,0.0428734996117814,0.00539970808857767,0.0322900717581691,0.0534569274653936,2.18572722317422e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42346,0.0404469161775464,0.00551945699057739,0.0296287804760148,0.0512650518790781,2.47126210747395e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42346,0.0342259036147003,0.00539515912450453,0.0236513917306715,0.0448004154987292,2.31483548309586e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42346,0.0432773688073569,0.00548604379561419,0.0325247229679531,0.0540300146467607,3.29556432029202e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42346,0.0422635812598737,0.00545844952937703,0.0315650201822947,0.0529621423374526,1.04356190569608e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42346,0.0456733660685876,0.00543870011312041,0.0350135138468715,0.0563332182903036,5.00993717295075e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42346,0.048795499012758,0.00530888220450693,0.0383900898919244,0.0592009081335915,4.45696904445339e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42346,0.0490210124313634,0.00522205614890626,0.0387857823795072,0.0592562424832197,7.15391520308029e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42346,0.0472170120961386,0.00539679866153792,0.0366392867195243,0.0577947374727529,2.41036634506672e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42346,0.0365450748482804,0.0054944499977264,0.0257759528527367,0.0473141968438241,3.02063382745289e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42346,0.0435278078979676,0.00541934279043273,0.0329058960287195,0.0541497197672157,1.04071820391947e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42346,0.041420825266363,0.00538923613248031,0.0308579224467016,0.0519837280860244,1.62745289837288e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42346,0.0447251720353018,0.00541523470856849,0.0341113120065076,0.0553390320640961,1.60660389372955e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42346,0.0488991221616156,0.00530105404503686,0.0385090562333434,0.0592891880898879,3.28037910333408e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42346,0.050484469828276,0.00520452392461489,0.0402836029360309,0.0606853367205212,3.57342953211395e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42346,0.0462499574371317,0.00540238105756741,0.0356612905642996,0.0568386243099639,1.24182510028727e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42346,0.0340001517583979,0.00538762683527353,0.0234404031612618,0.044559900355534,2.86533282891267e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42346,0.0444412259036737,0.00507228253635524,0.0344995521324174,0.05438289967493,2.15877236252077e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42346,0.0431667140851552,0.00513227411188599,0.0331074568258587,0.0532259713444517,4.48770214124974e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42346,0.0443261788192049,0.0050506879267927,0.0344268304826912,0.0542255271557186,1.89632181360851e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42346,0.0386715798766797,0.00495930889348402,0.028951334445451,0.0483918253079084,6.7735529531791e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42346,0.0335788339893595,0.00497730705445486,0.0238233121626279,0.043334355816091,1.57916319216759e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42346,0.0434834326838555,0.00501340266876926,0.0336571634530678,0.0533097019146433,4.68021322204089e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42346,0.0373033659357791,0.00534013451180686,0.0268367022926376,0.0477700295789205,2.9755508070672e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42346,0.0494405247902882,0.00524436346133021,0.039161572406081,0.0597194771744955,4.89958401914109e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42346,0.0488690309717518,0.00522892380411188,0.0386203403156926,0.0591177216278111,1.05604276161035e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42346,0.0467452033676509,0.0050998653471871,0.0367494672871642,0.0567409394481376,5.63010983835357e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42346,0.0483214846935357,0.005047682995865,0.0384280260216403,0.0582149433654311,1.22150319067954e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42346,0.0506110578613348,0.00507353812206691,0.0406669231420836,0.0605551925805859,2.36198934859541e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42346,0.04354711739751,0.00501101401982217,0.0337255299186585,0.0533687048763614,4.03927121495666e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42346,0.0398307322867263,0.00544265137933745,0.0291631355832249,0.0504983289902277,2.65781608372365e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42346,0.0488612808012445,0.00510055924852411,0.0388641846741373,0.0588583769283517,1.14653499525588e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42346,0.0496610846295864,0.00515048559141385,0.0395661328704153,0.0597560363887576,6.27907387896544e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42346,0.05245545114833,0.00515511273865021,0.0423514301805756,0.0625594721160844,3.13881411192214e-24
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42346,0.041791163109801,0.00507911219851077,0.0318361032007199,0.0517462230188821,2.08084637258095e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42346,0.0379775101212637,0.00508539042596037,0.0280101448863814,0.0479448753561461,8.65730625784624e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42346,0.0494457408958084,0.0051078102104036,0.0394344328834173,0.0594570489081994,4.32751366445826e-22
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42346,0.0452796718418448,0.00543914633383033,0.0346189450275373,0.0559403986561522,9.277737753713e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23523.Concentration of IDL Particles,42346,0.0302290184601153,0.0049422849643563,0.020542139929977,0.0399158969902536,9.84232055561212e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23524.Total Lipids in IDL,42346,0.025739927155269,0.00509066208748745,0.0157622294637936,0.0357176248467444,4.33214654424812e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23525.Phospholipids in IDL,42346,0.0312109619763163,0.00510181850500859,0.0212113977064994,0.0412105262461331,9.76812853255118e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23526.Cholesterol in IDL,42346,0.0199729364219861,0.00508866560416973,0.00999915183781339,0.0299467210061587,8.71769247730445e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42346,0.0182812423670968,0.00509299886277933,0.00829896459604926,0.0282635201381442,0.000332537508356037
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23528.Free Cholesterol in IDL,42346,0.0242185823548358,0.00507361433760292,0.0142742982531341,0.0341628664565375,1.83057443833753e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23529.Triglycerides in IDL,42346,0.045404112533597,0.0054386043470856,0.0347444480133092,0.0560637770538847,7.60067845744632e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42346,0.0366007503910275,0.00497264145588866,0.0268543731374857,0.0463471276445692,1.94211262055679e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23531.Total Lipids in Large LDL,42346,0.0252223930070887,0.00504666101023802,0.0153309374270222,0.0351138485871552,5.87223756678544e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23532.Phospholipids in Large LDL,42346,0.0249064716893678,0.0050080623022407,0.0150906695769761,0.0347222738017596,6.66617739418263e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23533.Cholesterol in Large LDL,42346,0.0229110155916073,0.00505769972257212,0.012997924135366,0.0328241070478487,5.95230369151508e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42346,0.024171778860814,0.00505806508580349,0.0142579712926392,0.0340855864289889,1.78199361727319e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42346,0.0190427566943993,0.00506501114359738,0.00911533485294846,0.0289701785358502,0.000170876129922718
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23536.Triglycerides in Large LDL,42346,0.0425220808407667,0.00543510773525687,0.0318692696796632,0.0531748920018702,5.52401046229096e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42346,0.0380781135204843,0.0049983284858461,0.0282813896882259,0.0478748373527427,2.74859074142e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42346,0.0310176194505917,0.00503230503177006,0.0211543015883224,0.040880937312861,7.31415399092999e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42346,0.0283463755478619,0.00502392206086659,0.0184994883085634,0.0381932627871605,1.71276035439164e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42346,0.0301426594927914,0.00502108322091617,0.0203013363797957,0.0399839826057871,1.98538683753948e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42346,0.0331354119840662,0.00504577719327913,0.0232456886852391,0.0430251352828932,5.32832377928015e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42346,0.0208261187892017,0.00501087818671409,0.0110047975432421,0.0306474400351614,3.25659439676535e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42346,0.0412711428756345,0.00545747120550453,0.0305744993128456,0.0519677864384233,4.22171768233446e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42346,0.0399079763258592,0.00497026437840764,0.0301662581441802,0.0496496945075382,1.06279725095895e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23545.Total Lipids in Small LDL,42346,0.0328118972048213,0.00498184305274634,0.0230474848214384,0.0425763095882041,4.68079266402327e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23546.Phospholipids in Small LDL,42346,0.0304247293831031,0.00494736089552298,0.0207279020278781,0.0401215567383282,7.98839979184116e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23547.Cholesterol in Small LDL,42346,0.0310356766183471,0.00498098798720881,0.0212729401634179,0.0407984130732764,4.78133154282932e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42346,0.0344887855271881,0.00500864807233049,0.0246718353054204,0.0443057357489559,6.00535211916964e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42346,0.0202233720663339,0.00497580456718071,0.0104707951146597,0.0299759490180081,4.84481973717926e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23550.Triglycerides in Small LDL,42346,0.0417993938472899,0.00548684329636601,0.0310451809864125,0.0525536067081673,2.74978189161439e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42346,0.00204827492499036,0.00571482761428872,-0.00915278719901553,0.0132493370489962,0.720039177003093
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42346,-0.00400051912024815,0.00574517184591752,-0.0152610559382465,0.00726001769775019,0.48623628140687
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42346,-0.00616003909703731,0.00578263070529175,-0.0174939952794091,0.00517391708533453,0.286775191299147
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42346,-0.0059255559154765,0.00568413663422332,-0.0170664637185542,0.0052153518876012,0.297211847574486
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42346,-0.00924821306641687,0.00574104292883487,-0.0205006572069332,0.00200423107409947,0.107226769492242
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42346,0.00565265104341779,0.00544001423672992,-0.00500977686057286,0.0163150789474084,0.298783124467675
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42346,0.0364982983386922,0.00535126099620673,0.026009826786127,0.0469867698912574,9.46875155016037e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42346,-0.0252944602208375,0.00595671382379621,-0.0369696193154781,-0.0136193011261969,2.18746319821053e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23559.Total Lipids in Large HDL,42346,-0.0290030966941943,0.00596452416524248,-0.0406935640580695,-0.017312629330319,1.17193505104357e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23560.Phospholipids in Large HDL,42346,-0.0318769398842725,0.00595761059116665,-0.0435538566429591,-0.0202000231255859,8.91208122260454e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23561.Cholesterol in Large HDL,42346,-0.0290021193931911,0.00590404706454178,-0.040574051639693,-0.0174301871466893,9.11229800550287e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42346,-0.0306524799663222,0.00589279633714544,-0.0422023607871273,-0.0191025991455171,2.0045466667292e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42346,-0.0228163328851206,0.00591706446442221,-0.0344137792353882,-0.0112188865348531,0.000115795917740589
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23564.Triglycerides in Large HDL,42346,0.019664217727753,0.00553116923620522,0.00882312602479078,0.0305053094307152,0.000379068113117794
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42346,-0.0328526180152804,0.00555995986811738,-0.0437501393567905,-0.0219550966737704,3.53162871855301e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42346,-0.0316532237154243,0.00551599361733204,-0.0424645712053951,-0.0208418762254535,9.76571414390341e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42346,-0.0286942420570568,0.00549034652841856,-0.0394553212527572,-0.0179331628613564,1.75574110213148e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42346,-0.0396963698740861,0.00554185427246658,-0.0505584042481206,-0.0288343355000516,8.31227826157889e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42346,-0.041541579680794,0.00551289662093389,-0.0523468570578244,-0.0307363023037636,5.18843593487295e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42346,-0.0305867211280493,0.00564211942928654,-0.041645275209451,-0.0195281670466477,6.02651829758971e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42346,0.0264825185869909,0.00536354653297283,0.0159699673823642,0.0369950697916177,8.01007399353162e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42346,-0.0100592698693658,0.00511867980818405,-0.0200918822934065,-2.66574453250661e-05,0.049411196286522
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23573.Total Lipids in Small HDL,42346,-0.008199420368991,0.00515862792787215,-0.0183103311076204,0.00191149036963842,0.111981155331273
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23574.Phospholipids in Small HDL,42346,-0.0102837321338102,0.00518923620789735,-0.020454635101289,-0.000112829166331417,0.0475288057570665
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23575.Cholesterol in Small HDL,42346,-0.0150193689518374,0.00511301461379859,-0.0250408775948826,-0.00499786030879217,0.00331467439088004
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42346,-0.0188081647770507,0.00508675932647972,-0.028778213056951,-0.00883811649715044,0.000218640215588591
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42346,-0.00163652031424987,0.00524247135767241,-0.0119117641752878,0.00863872354678805,0.754919463559194
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23578.Triglycerides in Small HDL,42346,0.036741834013998,0.0054571786374744,0.0260457638845482,0.0474379041434479,1.73393970242097e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,0.00679731441299675,0.00525774003920364,-0.00350785606384238,0.0171024848898359,0.196096707872225
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,0.000492169869945821,0.00542110124673008,-0.0101331885736451,0.0111175283135368,0.927662637631372
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,0.005415181275515,0.00536456031697099,-0.00509935694574814,0.0159297194967781,0.312784775656738
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,-0.00705543792402813,0.00544511599301572,-0.0177278652703389,0.00361698942228267,0.195089741022604
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41861,-0.00238067376937158,0.00537492203622754,-0.0129155209603776,0.00815417342163439,0.657829374159428
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42229,0.0441421969243115,0.0052059533857621,0.0339385282882178,0.0543458655604052,2.51024211064326e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42229,-0.000165943712652935,0.00547519190140055,-0.010897319839398,0.0105654324140921,0.975821647888384
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42229,-0.00473112294632801,0.00548267134390878,-0.0154771587803892,0.00601491288773319,0.388195705920312
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42229,0.0186207689418852,0.00539476220725584,0.00804703501566376,0.0291945028681067,0.000558960674909702
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42229,-0.0118517407332781,0.00536532885210658,-0.022367785283407,-0.00133569618314918,0.0271954792011632
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42345,0.0448794436158853,0.00532057378973736,0.0344511189880001,0.0553077682437706,3.65275954155514e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42345,0.0213444275079606,0.00516574317391307,0.011219570887091,0.0314692841288303,3.61975937784885e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42345,0.015112536797145,0.00532224378227949,0.00468093898387725,0.0255441346104128,0.0045252921435256
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42345,0.0322220057714205,0.00510297357490444,0.0222201775646078,0.0422238339782332,2.80009443194416e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42345,-0.0348612711995681,0.00507762491265614,-0.0448134160283741,-0.024909126370762,6.91531289785442e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42346,0.0203215020452953,0.00516445967044121,0.0101991610912305,0.03044384299936,8.36681448097561e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42346,0.00326223858895189,0.00537170276603293,-0.00726629883247265,0.0137907760103764,0.543661890539443
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42346,-0.00086700816586228,0.00542963497160412,-0.0115090927102064,0.00977507637848179,0.873135020367552
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42346,0.0140073339648201,0.00523633508655349,0.00374411719517529,0.024270550734465,0.00748158506570791
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42346,-0.00725981743921122,0.00532122615200191,-0.017689420697135,0.00316978581871253,0.172492454320901
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42346,-0.00176371280591917,0.00536085515536518,-0.0122709889104349,0.00874356329859657,0.742162130658592
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42346,0.0141910581212273,0.0052160916253742,0.00396751853549391,0.0244145977069608,0.00652432012155091
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42346,0.0234871980149991,0.00510827288994914,0.0134749831506987,0.0334994128792994,4.30800232985638e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42346,-0.000474036140968198,0.005382465800279,-0.011023669109515,0.0100755968275786,0.929822029967182
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42346,-0.00961916235677735,0.00526511681361579,-0.0199387913114643,0.000700466597909599,0.0677283056808746
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42346,0.0295637007307875,0.00523253877736557,0.019307924727151,0.0398194767344241,1.63802938361957e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42346,-0.0058066413104,0.00542611200410456,-0.0164418208384449,0.00482853821764495,0.284580761485984
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42346,-0.00960618097278311,0.00547140732545264,-0.0203301393306703,0.00111777738510406,0.079161950893967
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42346,0.021121064139875,0.00513089106310215,0.0110645176561948,0.0311776106235553,3.87098386408533e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42346,-0.000420988212061345,0.00540456039941856,-0.0110139265949217,0.010171950170799,0.937912764689243
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42346,0.0263804295488242,0.00493380733264011,0.0167101671768496,0.0360506919207988,9.09844311138484e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42346,-0.0215057757039156,0.00522704738100135,-0.0317507885706782,-0.0112607628371529,3.90677937595039e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42346,-0.0277701414407473,0.00522105331818081,-0.0380034059443817,-0.0175368769371129,1.06120225092331e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42346,0.00395984339946021,0.00502122285123911,-0.00588175338896844,0.0138014401878889,0.430347579979454
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42346,0.0152594673268964,0.00540000014694415,0.00467546703888587,0.0258434676149069,0.00472297745863511
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42346,-0.00413667713769656,0.00500450169097204,-0.0139455004520018,0.00567214617660864,0.408483793120623
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42346,-0.0127888423050099,0.00542903355599276,-0.0234297480747557,-0.00214793653526411,0.0185054829366775
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42346,-0.00118676167302364,0.00505579166030549,-0.0110961133272224,0.00872258998117513,0.814419545840817
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42346,-0.01908184613746,0.00542038412356602,-0.0297057990196494,-0.00845789325527061,0.00043237646079229
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42346,0.0133282892693047,0.00541455113800349,0.00271576903881791,0.0239408094997916,0.0138458327145974
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42346,-0.0299540281130571,0.00512042684401188,-0.0399900647273203,-0.0199179914987938,5.03542159642986e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42346,0.00907828057998224,0.00499549287297397,-0.000712885451046738,0.0188694466110112,0.069194812574019
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42346,0.0322430316634219,0.00516088087814114,0.0221277051422652,0.0423583581845785,4.29706196767615e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42346,-0.0334791953032643,0.00553712158227971,-0.0443319536045325,-0.0226264370019961,1.52208519387963e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42346,0.0080706612649123,0.00531837403995589,-0.00235335185340125,0.0184946743832258,0.129163169101276
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42346,-0.018427434841099,0.00507474448265383,-0.0283739340271005,-0.00848093565509746,0.000283173344664423
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42346,0.00397827274996865,0.00510709565565928,-0.00603163473512353,0.0139881802350608,0.436011581328658
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42346,0.0243816438678318,0.00507150879516922,0.0144414866293001,0.0343218011063634,1.54465145670716e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42346,-0.0273014482204107,0.00543163754660234,-0.0379474578117512,-0.0166554386290701,5.06409559227872e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42346,0.0167896783804051,0.00543108139255825,0.00614475885099095,0.0274345979098193,0.00199627431558783
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42337,-0.0126695009368974,0.00565188497745935,-0.0237471954927178,-0.00159180638107712,0.0250011583363841
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42337,-0.00750293646753188,0.00534339074812129,-0.0179759823338496,0.00297010939878584,0.160297017113486
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42337,-0.0208282557064912,0.00517679485241501,-0.0309747736172246,-0.0106817377957578,5.76879894786647e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42337,0.0216379285602821,0.0059066839474716,0.0100608280232378,0.0332150290973264,0.000249969453334607
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42337,0.0309798289265418,0.00563751321833096,0.0199303030186131,0.0420293548344705,3.97309895044013e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42346,-0.0122623535602358,0.00549228403157114,-0.0230272302621152,-0.00149747685835634,0.025588730397077
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42346,-0.0191794944049109,0.00567728679974342,-0.030306976532408,-0.00805201227741382,0.000731510021428325
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42346,-0.0240933387751559,0.00571326758707366,-0.0352913432458202,-0.0128953343044915,2.49135934319835e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42346,0.0124052073757563,0.00537697167665734,0.00186634288950795,0.0229440718620047,0.0210647431474194
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42346,0.0402669155569581,0.00560258534853215,0.0292858482738351,0.0512479828400811,6.96992162691093e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42346,0.0339011164304356,0.00556828541903304,0.0229872770091308,0.0448149558517403,1.17329122564409e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42346,-0.0445307954723505,0.00552092796244622,-0.0553518142787451,-0.0337097766659559,7.90147874197468e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42346,-0.0455080956780887,0.00548883032110951,-0.0562662031074633,-0.034749988248714,1.23096010031219e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42346,-0.0193257194076415,0.00577633510745655,-0.0306473362182563,-0.00800410259702663,0.000823133325714456
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42346,0.0475456824508411,0.00544833364352021,0.0368669485095415,0.0582244163921407,2.93626456781586e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42346,-0.0151880458861135,0.0053402948126012,-0.0256550237188119,-0.00472106805341517,0.00446132875040461
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42346,-0.0210010541567976,0.00533900363752365,-0.0314655012863439,-0.0105366070272512,8.41423222891312e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42346,-0.0261010483856415,0.00538857786769455,-0.0366626610063228,-0.0155394357649601,1.28847814380116e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42346,0.0185685991541209,0.00532905595684004,0.00812364947871437,0.0290135488295273,0.000494834888103044
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42346,0.0473453942178859,0.00550177983359983,0.0365619057440303,0.0581288826917416,8.45590061985761e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51558,0.00170983627991849,0.00445642831572723,-0.00702476321890687,0.0104444357787439,0.701220305855103
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51558,0.00233937485412925,0.00433905309276106,-0.00616516920768242,0.0108439189159409,0.589792798468575
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50130,-0.0029004923373648,0.00411908693041515,-0.0109739027209785,0.00517291804624889,0.481341561982497
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50130,0.00246749499855386,0.00452826680688558,-0.00640790794294187,0.0113428979400496,0.585821657986107
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50130,-0.00172122055017879,0.00441959109571934,-0.0103836190977887,0.00694117799743111,0.696945445202014
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50130,-0.000446403485532791,0.00403115765233105,-0.00834747248410164,0.00745466551303606,0.911824947004174
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24009.Traffic intensity on the nearest road,51558,-0.0346577538884065,0.0479685240753773,-0.128676061076146,0.0593605532993331,0.469988335469142
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24010.Inverse distance to the nearest road,51558,-0.00164689883620102,0.00388655537085296,-0.00926454736307283,0.00597074969067078,0.671757664262915
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51558,0.0037756603280368,0.0038471406737301,-0.0037647353924742,0.0113160560485478,0.326396344582954
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24012.Inverse distance to the nearest major road,51558,-0.00449574371428823,0.0039228758850084,-0.0121845804489047,0.00319309302032824,0.25179391899196
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24013.Total traffic load on major roads,51558,-0.0525282657768344,0.0336640696176292,-0.118509842227388,0.0134533106737189,0.118687592372496
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51558,-0.0643100599009299,0.0327640876274812,-0.128527671650793,-9.24481510668623e-05,0.0496792807066547
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51558,-0.0013131552799731,0.00443335172882136,-0.010002524668463,0.00737621410851677,0.767080702392618
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51558,-0.000156876383986061,0.00442240604326731,-0.00882479222878999,0.00851103946081787,0.971702824783044
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51558,-0.000842694258764025,0.00437225945556834,-0.00941232279167797,0.00772693427414991,0.847167037486281
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51506,-0.00281868291424671,0.00435818995319792,-0.0113607352225146,0.00572336939402121,0.517796910565662
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51558,-0.00651407471950755,0.00391823264108156,-0.0141938106960274,0.00116566125701231,0.096425914794416
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24021.Average evening sound level of noise pollution,51558,-0.00647334027455235,0.00391872850910971,-0.0141540481524074,0.00120736760330268,0.0985693593924349
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51558,-0.00650198073822552,0.00391829273791405,-0.0141818345045371,0.00117787302808602,0.0970509969483899
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51558,-0.00644677949728615,0.00391845398433799,-0.0141269493065886,0.00123339031201632,0.0999353141185257
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51558,-0.00643041440191162,0.0039184120259973,-0.0141105019728663,0.00124967316904308,0.100795571239276
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2405.Number of children fathered,39865,-0.0100756252970502,0.0369096515137567,-0.0824185422640133,0.0622672916699129,0.784873275828845
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49313,0.00576895163899032,0.00451204171981483,-0.00307465013184676,0.0146125534098274,0.20106401371041
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49313,-0.00704253436459454,0.00405556039383421,-0.0149914327365096,0.000906364007320521,0.0824884302753224
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24502.Water percentage, buffer 1000m",49313,0.00572516522077542,0.00411710729466971,-0.00234436507677721,0.0137946955183281,0.16436834118488
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49313,0.00561099346041009,0.00422443477623205,-0.00266889870100473,0.0138908856218249,0.184119356488939
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49313,-0.0078193953512659,0.00407178406012593,-0.0158000921091127,0.000161301406580923,0.0548233348546839
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24505.Water percentage, buffer 300m",49313,0.011027051529103,0.00414304446160742,0.00290668438435249,0.0191474186738536,0.00778362313065536
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51698,0.00369545640038224,0.00436543288449915,-0.00486079205323608,0.0122517048540006,0.397267871268965
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51698,0.00228788510047935,0.00408066313886875,-0.00571021465170341,0.0102859848526621,0.575031496040255
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24508.Distance (Euclidean) to coast,51698,-0.00408483262947559,0.00385781417140939,-0.011646148405438,0.00347648314648682,0.289681105140343
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35407,0.0181836220805427,0.0453966785509409,-0.0707938678793015,0.107161112040387,0.688765520650457
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2704.Years since last cervical smear test,38244,0.00224218001173994,0.0389147389558666,-0.0740307083417587,0.0785150683652386,0.954054376372526
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2714.Age when periods started (menarche),40629,0.0644354346168744,0.0311073436498814,0.00346504106310684,0.125405828170642,0.0383447561212715
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2734.Number of live births,40977,-0.0709699196217203,0.0299855711935143,-0.129741639161008,-0.0121982000824323,0.0179585960709673
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2744.Birth weight of first child,39188,-0.0402261327761376,0.0321233676457314,-0.103187933361771,0.022735667809496,0.210512127228223
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2754.Age at first live birth,37978,-0.0072658633202723,0.0069012917657591,-0.0207923951811601,0.00626066854061554,0.292449443009469
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2764.Age at last live birth,37950,-0.00879148466434597,0.0063611121126567,-0.0212592644051531,0.00367629507646117,0.166986307403697
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2794.Age started oral contraceptive pill,36901,8.65568489093864e-05,0.00999113483489883,-0.0194960674274923,0.0196691811253111,0.993087945401388
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2804.Age when last used oral contraceptive pill,36139,-0.00784030236725842,0.00745544305646033,-0.0224529707579207,0.00677236602340383,0.293009936349521
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2867.Age started smoking in former smokers,36100,-0.0356558470349454,0.00749115809381645,-0.0503385168988257,-0.0209731771710652,1.97802917226365e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35930,-0.0929958248916261,0.0526838352138361,-0.196256141910745,0.0102644921274927,0.0775808364216307
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35926,-0.0767355474516977,0.0572702592707295,-0.188985255622327,0.0355141607189322,0.180328052035805
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35944,-0.0699446870613498,0.0595772178721117,-0.186716034090689,0.0468266599679891,0.240429510673582
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35917,-0.111382790725506,0.0587514953710421,-0.226535721652749,0.00377014020173604,0.0580255106353046
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28739.Difficulty with standing for long periods,35951,0.00511521821943105,0.0441519379014201,-0.0814225800673523,0.0916530165062144,0.90777098615857
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28740.Difficulty with taking care of household responsibilities,35973,-0.0236007767925367,0.0488261828335368,-0.119300095146269,0.0720985415611954,0.628853537090603
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28741.Difficulty learning a new task,35913,-0.0710274776434497,0.0569066094480795,-0.182564432161685,0.040509476874786,0.212022904146588
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28742.Difficulty with joining in community activities,35651,-0.00223688462286294,0.0601213565732768,-0.120074743506485,0.115600974260759,0.970321780242657
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35930,-0.0337601614583506,0.0505864793848674,-0.132909661052691,0.0653893381359895,0.504555378935613
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35973,0.0446624770229199,0.0765811071758741,-0.105436493041793,0.194761447087633,0.559774781445744
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35628,0.0267188625663234,0.0426045054472833,-0.0567859681103519,0.110223693242999,0.530591675679076
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2897.Age stopped smoking,36102,0.0638688266548457,0.00701311825080575,0.0501231148832664,0.077614538426425,1.09006574672472e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35247,0.0297931257590479,0.0158184901916477,-0.00121111501658149,0.0607973665346774,0.0596891043938627
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35247,-0.0439665651703473,0.0177904108588266,-0.0788357704536474,-0.00909735988704724,0.0134872269226711
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35247,0.103386760045741,0.0582982845864146,-0.0108778777436314,0.217651397835114,0.0762110668804375
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35247,-0.0539699726694138,0.0675656882978173,-0.186398721733136,0.0784587763943081,0.42445059814099
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35247,-0.134546832940994,0.0848525254702545,-0.300857782862692,0.0317641169807054,0.112869824344825
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35247,0.0439205304065814,0.0691397200746001,-0.0915933209396349,0.179434381752798,0.525293886898524
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35247,-0.010614721259429,0.028947588770182,-0.0673519952489857,0.0461225527301277,0.713864889308138
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35247,0.00638568973303608,0.0496275592937948,-0.0908843264828018,0.103655705948874,0.897621268722964
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35201,0.0234137580766951,0.0608658032254182,-0.0958832162451245,0.142710732398515,0.700489343744613
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29003.Recent feelings of depression,35192,-0.0103007180347624,0.0593801510718776,-0.126685814135643,0.106084378066118,0.862287290400856
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35206,-0.10143959161208,0.0470744039680493,-0.193705423389457,-0.00917375983470377,0.0312109943412007
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29005.Recent feelings of tiredness or low energy,35207,-0.0486373233777797,0.0459582326187885,-0.138715459310605,0.0414408125550458,0.289963937942266
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29006.Recent poor appetite or overeating,35218,0.0117343502604937,0.0709054960213362,-0.127240421941325,0.150709122462313,0.868561658432397
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29007.Recent feelings of inadequacy,35184,-0.0641144275964709,0.0683071934451844,-0.197996526749032,0.0697676715560905,0.3479642667908
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29008.Recent trouble concentrating on things,35216,-0.113112026391745,0.0655817353687198,-0.241652227714436,0.0154281749309454,0.0846240616342041
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35210,-0.0429419174059834,0.110391148268264,-0.259308568011781,0.173424733199814,0.697291521567811
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35190,0.0132518577519497,0.122888351988095,-0.227609312144717,0.254113027648616,0.914128946600775
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#0.Substances taken for depression_None of options listed,36225,-0.037201084138363,0.0322999235247519,-0.100508934246877,0.0261067659701507,0.249467470318275
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36225,-0.140853952826787,0.081863915244793,-0.301307226706581,0.019599321053007,0.0853698709078336
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36225,-0.0415090287880016,0.0330796434847937,-0.106345130018197,0.0233270724421941,0.209585483160542
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36225,-0.168159316162824,0.099513392618352,-0.363205565694794,0.026886933369146,0.0911075071961407
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36225,-0.0339132974035919,0.0835260251463677,-0.197624306690472,0.129797711883289,0.684739727461622
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36225,-0.0232686386182534,0.0882718256061965,-0.196281416806398,0.149744139569892,0.792094264879176
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36225,0.0630331069219661,0.0904580454397142,-0.114264662139874,0.240330875983806,0.485937573800405
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36225,-0.0660502231154298,0.0904839887635509,-0.24339884109199,0.11129839486113,0.465435369146644
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36225,-0.148333643629739,0.0589671378533447,-0.263909233822295,-0.0327580534371838,0.0119074413492473
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36225,-0.063427609688438,0.0295729044437685,-0.121390502398224,-0.00546471697865176,0.0320039696468779
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36225,-0.0390796611063884,0.0524027885844491,-0.141789126731909,0.0636298045191318,0.455840133729563
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36225,-0.111169592958245,0.0810138612130105,-0.269956760935745,0.0476175750192556,0.170035846501315
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36225,-0.152771392103938,0.114180148556316,-0.376564483274317,0.0710216990664403,0.180944408991432
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36225,-0.130365743479271,0.0779337535989312,-0.283115900533176,0.0223844135746341,0.0944158124833397
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36225,-0.0979183618681719,0.112043603565089,-0.317523824855747,0.121687101119403,0.382185760301474
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36225,-0.0217966307609946,0.110025867247538,-0.23744733056617,0.193854069044181,0.84296895070555
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36225,-0.0838979161596712,0.0638349193897056,-0.209014358163494,0.0412185258441518,0.188789818741175
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36225,-0.11187626524183,0.05925727552265,-0.228020525266224,0.00426799478256412,0.0590704218040615
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36225,-0.13541641696935,0.0872123711361357,-0.306352664396175,0.0355198304574764,0.120534984310023
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35114,-0.0273090906774882,0.0552471397888793,-0.135593484663692,0.0809753033087151,0.621107183164634
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29059.Recent inability to stop or control worrying,35127,-0.0315343417577964,0.0563910224468274,-0.142060745753578,0.0789920622379853,0.576040514754892
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29060.Recent worrying too much about different things,35124,-0.086037933895915,0.0528224939454141,-0.189570022028927,0.0174941542370967,0.103405871986403
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29061.Recent trouble relaxing,35121,-0.0776899233496191,0.0572089542506835,-0.189819473680959,0.0344396269817205,0.174514487236305
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29062.Recent restlessness,35137,-0.0625223724119516,0.0834169327341132,-0.226019560570813,0.10097481574691,0.453575598548583
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29063.Recent easy annoyance or irritability,35109,-0.122609640644822,0.0586628482061322,-0.237588823128842,-0.00763045816080316,0.0366538474015331
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29064.Recent feelings of foreboding,35110,-0.0571315584633087,0.0651773696744964,-0.184879203025322,0.0706160860987043,0.380763916571132
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36225,-0.0609327843335295,0.0371322205837937,-0.133711936677765,0.0118463680107063,0.100848794047112
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36225,-0.0747779314512683,0.0658561860431215,-0.203856056095786,0.0543001931932498,0.256215827042643
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36225,-0.0952240548864215,0.0794923819360454,-0.251029123481071,0.0605810137082275,0.230995689810753
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36225,-0.120629691936698,0.0758363353230512,-0.269268909169878,0.0280095252964827,0.111731466860208
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36225,-0.0366055009059994,0.0564842577268218,-0.14731464605057,0.0741036442385713,0.516963723866261
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36225,-0.0582764428866465,0.0602962628036107,-0.176457117981724,0.0599042322084305,0.33382641930909
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36225,-0.0702411318970343,0.0602777369248746,-0.188385496269789,0.04790323247572,0.243940567296242
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36225,-0.0866386535712252,0.0609495415554159,-0.20609975501984,0.0328224478773901,0.155221142931378
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36225,-0.139156936395434,0.0766421746783052,-0.289375598764912,0.0110617259740446,0.0694635075928371
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29076.Felt loved as a child,35106,-0.0371571035511494,0.048108446495663,-0.131449658682649,0.0571354515803501,0.439931342264861
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29077.Physically abused by family as a child,35129,0.03077472620576,0.0708851778355811,-0.108160222351979,0.169709674763499,0.664196064013335
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29078.Felt hated by family member as a child,35115,0.114435723136354,0.069418294610888,-0.0216241343009868,0.250495580573694,0.0993041823374554
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29079.Sexually molested as a child,35070,-0.141458501338754,0.0929579178161536,-0.323656020258415,0.0407390175809076,0.12812613687541
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29080.Someone to take to doctor when needed as a child,35087,-0.0461497997816138,0.0648023331577208,-0.173162372770746,0.0808627732075189,0.476392284472316
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35121,-0.0140713257893231,0.103810583080454,-0.217540068627012,0.189397417048366,0.892183152152256
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35075,-0.0230156888882072,0.0784180901321194,-0.176715145547161,0.130683767770747,0.769150558060634
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35125,-0.0930553280697024,0.0924230784638169,-0.274204561858784,0.0880939057193787,0.314052356027169
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35113,0.12337023013886,0.121682112844742,-0.115126711036834,0.361867171314554,0.310684721371602
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35112,0.0244243442029831,0.115193703289955,-0.201355314245328,0.250204002651295,0.832092129465691
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29086.Experienced a violent or sexual assault,35128,-0.00254818700403051,0.109969538661101,-0.218088482779789,0.212992108771728,0.981514049516976
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29087.Experienced a life-threatening injury or illness,35120,0.0776485409202702,0.0526887779798394,-0.0256214639202151,0.180918545760755,0.140609940745318
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29088.Experienced a marital separation or divorce,35128,-0.00598668278202952,0.0539288594952552,-0.11168724739273,0.0997138818286706,0.911611582364152
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29089.Experienced the death of a spouse or partner,35134,0.0638177337769007,0.0572961752285421,-0.0484827696710418,0.176118237224843,0.26540068203309
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35126,-0.0391223695302221,0.0690183478160091,-0.1743983312496,0.0961535921891558,0.57084425076849
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35124,-0.151744945553914,0.0429936957711345,-0.236012589265337,-0.0674773018424899,0.000419553691024483
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34400,-0.118621785129536,0.0540814981531281,-0.224621521509667,-0.0126220487494048,0.0283234300238506
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34423,-0.111154034793079,0.0560135260743624,-0.220940545898829,-0.00136752368732851,0.0472619054594749
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29104.Ever used cannabis,35125,0.0551773236266073,0.0790145714191471,-0.0996912363549211,0.210045883608136,0.485005529724353
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29108.Ever thought that life not worth living,35096,-0.0858991086512607,0.0600282374991993,-0.203554454149691,0.0317562368471699,0.152489371165929
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29109.Ever contemplated self-harm,35117,-0.120316512349097,0.091996307278515,-0.300629274614986,0.0599962499167927,0.190978121363736
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29111.Ever self-harmed,35125,-0.0711223015310316,0.161398501269358,-0.387463364018972,0.245218760956909,0.659473256908502
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35113,-0.0183177701181713,0.0871724095443003,-0.189175692825,0.152540152588657,0.833571370890748
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36849,-0.191312518673072,0.0894381675870123,-0.366611327143617,-0.0160137102025284,0.0324633393171763
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36849,-0.107160117366698,0.065371305814559,-0.235287876763234,0.0209676420298373,0.101201646028732
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36849,-0.0324954271356421,0.0784915819911097,-0.186338927838217,0.121348073566933,0.678886524873623
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36849,-0.18178382390022,0.11080484172539,-0.398961313681985,0.0353936658815456,0.100926432536862
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35105,-0.0833994237582176,0.0504507591424991,-0.182282911677516,0.0154840641610806,0.0983665561019592
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X29153.Pain or discomfort today,35116,-0.0202325588752989,0.0452698908282707,-0.108961544898709,0.0684964271481117,0.654940573934444
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29154.Anxiety or depression today,35116,-0.089302800910293,0.0594103803296609,-0.205747146356428,0.0271415445358423,0.132853336482205
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29166.Frequency of confiding in someone close,34940,-0.0648335832501073,0.0452104618198793,-0.153446088417071,0.0237789219168561,0.151615474722406
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35097,0.00988795048772526,0.0153805276799724,-0.0202578837650206,0.0400337847404711,0.520322007585768
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35097,0.000584030336972782,0.0157208176168053,-0.0302287721919657,0.0313968328659112,0.970366561946181
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35097,-0.0162306680915941,0.0196443672416613,-0.0547336278852502,0.022272291702062,0.408709839389948
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35097,-0.00448187153048858,0.0182426965664093,-0.0402375568006508,0.0312738137396736,0.805938248809356
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35097,-0.0431687239913761,0.0311540927971841,-0.104230745873857,0.0178932978911047,0.165905608503044
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35097,-0.0128481371924955,0.0148538592517551,-0.0419617013259354,0.0162654269409444,0.38709060506668
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35095,0.010590830965573,0.0159913485070306,-0.0207522121082069,0.0419338740393529,0.507814422832527
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35095,-0.0141207563857579,0.0245150509771263,-0.0621702563009254,0.0339287435294095,0.564634748419017
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35095,-0.0254117917614044,0.0355815203611705,-0.0951515716692985,0.0443279881464897,0.475140975646436
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35095,-0.0289871210177962,0.028759470438561,-0.0853556830773756,0.0273814410417833,0.313536273116646
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35095,-0.0339957079665176,0.0473893402747376,-0.126878814905003,0.0588873989719681,0.473173999829437
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35095,-0.0256891125430226,0.0216853921888264,-0.0681924812331223,0.0168142561470772,0.236212456968216
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34997,0.0186227820773002,0.0583646612258315,-0.0957719539253294,0.13301751807993,0.749680116412892
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29172.Freuency of feeling that lacks companionship,35080,-0.00872278819037137,0.0514417410300389,-0.109548600609248,0.0921030242285049,0.865357017346642
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29173.Frequency of feeling left out,35038,-0.0273999597904673,0.0561592283078577,-0.137472047273868,0.0826721276929338,0.625640591816473
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29174.Frequency of feeling isolated from others,35070,0.00907835978455156,0.0574545064447402,-0.103532472847139,0.121689192416242,0.874454716551856
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35111,0.0489536944797529,0.0457629077470666,-0.0407416047044976,0.138648993664003,0.284787081971106
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29176.Ability to make it through stressful events,35111,-0.00181741224424388,0.043538106169755,-0.0871521003369637,0.083517275848476,0.966704964158854
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29177.Quick recovery from stressful events,35111,0.0415412350738706,0.045269900190346,-0.0471877692992076,0.130270239446949,0.358847521019305
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29178.Hard to snap back when something bad happens,35111,-0.0262869961816131,0.0438199782138406,-0.112174153480741,0.0596001611175144,0.548605124365839
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29179.Comes through difficult times with little trouble,35111,0.065707825841331,0.0451949714756113,-0.0228743182508671,0.154289969933529,0.146034110573575
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35111,-0.0489966036490472,0.0446664788538839,-0.13654290220266,0.0385496949045652,0.272710754032174
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29181.General happiness,35084,0.0403103547669081,0.0459443412316828,-0.0497405540471902,0.130361263581006,0.380319524679733
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29182.Belief that own life is meaningful,34991,-0.0682898727555969,0.0457493876065784,-0.157958672464491,0.0213789269532968,0.135571543662174
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35446,0.15784755079386,0.0398832072557201,0.0796764645726484,0.236018637015071,7.64991353692834e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2946.Father's age,30155,-0.0493649681996177,0.0336478045217379,-0.115314665062224,0.0165847286629884,0.142673808634736
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2966.Age high blood pressure diagnosed,36656,0.00450190164361721,0.00726646852396332,-0.00974037666335089,0.0187441799505853,0.535576537771881
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51119,0.0225971587730978,0.00421526960105907,0.014335230355022,0.0308590871911735,8.36979288337067e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51120,0.0147963816224547,0.00444124317532478,0.00609154499881812,0.0235012182460913,0.000864954227074744
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30020.Haemoglobin concentration,51120,0.0178248083105933,0.0047770408546841,0.00846180823541245,0.0271878083857741,0.000190937369191218
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30030.Haematocrit percentage,51120,0.019389582689105,0.00464358040485714,0.010288165095585,0.028491000282625,2.98392083716893e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30040.Mean corpuscular volume,51120,0.00203650358599068,0.00407668659187156,-0.00595380213407758,0.0100268093060589,0.617397882970012
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51120,-0.000508249602143554,0.0040904899004812,-0.00852560980708671,0.0075091106027996,0.90111726738217
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51120,-0.00532185921012177,0.00399861536779677,-0.0131591453310034,0.0025154269107599,0.183227360777077
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51120,0.0306271229611705,0.00412252189728098,0.0225469800424997,0.0387072658798412,1.13235294525886e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30080.Platelet count,51120,0.0040231280512398,0.00405198202820738,-0.00391875672404666,0.0119650128265263,0.320779859127419
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30090.Platelet crit,51120,0.00322124827192248,0.00412725769416138,-0.00486817680863382,0.0113106733524788,0.435115938832625
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51120,-0.00235680098403575,0.00385970658696725,-0.00992182589449155,0.00520822392642006,0.541459747446203
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30110.Platelet distribution width,51120,0.00624642434514572,0.0040021325778422,-0.001597755507425,0.0140906041977164,0.11859152397945
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30120.Lymphocyte count,51081,-0.00503925331927908,0.00397208562545656,-0.0128245411451739,0.00274603450661577,0.204573406576518
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30130.Monocyte count,51081,0.0178439921706465,0.00405440971844861,0.00989734912248723,0.0257906352188058,1.08196807410117e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30140.Neutrophill count,51081,0.0230646719963312,0.00416870441390821,0.0148940113450711,0.0312353326475912,3.18738909677744e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30150.Eosinophill count,51081,0.0130734793548638,0.00398777909297478,0.00525743233263326,0.0208895263770944,0.00104565305439349
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30160.Basophill count,51081,0.0489907372742178,0.0241945950344631,0.00156933100667014,0.0964121435417654,0.0428935631026377
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30170.Nucleated red blood cell count,51081,-0.0484975124944419,0.121261354876991,-0.286169768053345,0.189174743064461,0.68920311727146
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30180.Lymphocyte percentage,51082,-0.0218484189180164,0.00394997543285677,-0.0295903707664157,-0.0141064670696172,3.21538409782097e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30190.Monocyte percentage,51082,0.00482428589584206,0.00400675628896199,-0.00302895643052344,0.0126775282222076,0.228588001867673
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30200.Neutrophill percentage,51082,0.0140591888051739,0.00392246328599381,0.00637116076462604,0.0217472168457218,0.000338749824026666
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30210.Eosinophill percentage,51082,0.00553685880117961,0.00395554421816168,-0.00221600786641727,0.0132897254687765,0.161595871769675
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30220.Basophill percentage,51082,0.000574117176778675,0.00394398866013982,-0.00715610059709537,0.00830433495065272,0.884264044701345
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51081,-0.0499262820277757,0.121333348819586,-0.287739645714164,0.187887081658613,0.680724417369712
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30240.Reticulocyte percentage,50740,0.0144139480512854,0.00426092429492497,0.00606253643323243,0.0227653596693383,0.000718727998188467
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30250.Reticulocyte count,50740,0.0168993251082683,0.00433633620325311,0.00840010614989222,0.0253985440666444,9.76282837912861e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30260.Mean reticulocyte volume,50740,0.018751507186186,0.00398963866854446,0.0109318153958389,0.0265711989765332,2.61703612266928e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30270.Mean sphered cell volume,50740,0.00936256201561084,0.00404243665230178,0.00143938617709936,0.0172857378541223,0.0205638415845032
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30280.Immature reticulocyte fraction,50740,0.016524371634045,0.00420957510123022,0.00827360443563376,0.0247751388324562,8.68458341797578e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50740,0.0183987159095211,0.00433998715062137,0.00989234109430326,0.026905090724739,2.25103176392769e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30300.High light scatter reticulocyte count,50740,0.0207183165127228,0.00439783970479102,0.0120985506913324,0.0293380823341132,2.48015750263062e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30500.Microalbumin in urine,36959,0.022114998047492,0.00691909272967685,0.00855357629732537,0.0356764197976586,0.00139794679185591
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51108,-0.0176093360274161,0.00443150022631627,-0.026295076470996,-0.00892359558383626,7.09990219302753e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30520.Potassium in urine,51071,-0.0256431505183934,0.00414975641534067,-0.0337766730924611,-0.0175096279443256,6.54674626621873e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30530.Sodium in urine,51054,0.00337590844271071,0.00436933627835208,-0.00518799066285936,0.0119398075482808,0.439745923666248
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30600.Albumin,48916,-0.0323359108346747,0.00427574102360056,-0.0407163632409318,-0.0239554584284176,4.12235005120192e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30610.Alkaline phosphatase,50696,0.0383180101142518,0.00419485054982755,0.0300961030365898,0.0465399171919138,7.13492231720147e-20
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30620.Alanine aminotransferase,50700,-0.00277786888948061,0.00449360483014102,-0.011585334356557,0.00602959657759579,0.536461441027455
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30630.Apolipoprotein A,48774,-0.0319900188122656,0.00468726596498112,-0.0411770601036286,-0.0228029775209026,9.05744306935044e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30640.Apolipoprotein B,50601,0.0316955103329831,0.00390928944315444,0.0240333030244004,0.0393577176415658,5.43153018897355e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30650.Aspartate aminotransferase,50635,0.0225094372040995,0.00428270344683714,0.0141153384482987,0.0309035359599003,1.48716561703369e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30660.Direct bilirubin,47558,-0.0122323146688599,0.00452436721491827,-0.0211000744100997,-0.00336455492762009,0.00686451962053825
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30670.Urea,50684,0.00341033070525078,0.00414376565290137,-0.00471144997443591,0.0115321113849375,0.410515537493442
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30680.Calcium,48916,-0.00918835015713736,0.00414319743162124,-0.017309017123115,-0.00106768319115974,0.0265869557272411
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30690.Cholesterol,50702,0.02477290991924,0.00394712194578794,0.0170365509054957,0.0325092689329844,3.53583805214253e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30700.Creatinine,50693,0.0226990943544107,0.00459243193690484,0.0136979277580772,0.0317002609507442,7.76205601938516e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30710.C-reactive protein,50640,0.044244208149255,0.00447106258332301,0.0354809254859419,0.0530074908125681,4.8698630824034e-23
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30720.Cystatin C,50709,0.0475392568925575,0.0045416396079026,0.0386376432610684,0.0564408705240466,1.40457445465321e-25
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50696,0.0139270143202886,0.00450852059114579,0.00509031396164287,0.0227637146789344,0.00201058326982223
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30740.Glucose,48899,-0.0134970022534895,0.00424350675231479,-0.0218142754880265,-0.00517972901895256,0.00147185522670969
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50667,0.0153735146756201,0.00433725396830607,0.00687249689774025,0.0238745324535,0.000394153620665276
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30760.HDL cholesterol,48906,-0.0330118032745721,0.00480737852244697,-0.0424342651785682,-0.0235893413705761,6.75640024815874e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30770.IGF-1,50574,-0.000117506954833804,0.00412186228606981,-0.00819635703553064,0.00796134312586303,0.9772570785578
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30780.LDL direct,50651,0.0314196062085522,0.00386747476218551,0.0238393556746686,0.0389998567424358,4.74980419711814e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30790.Lipoprotein A,46343,0.0112516642829249,0.00439814397811148,0.00263130208582636,0.0198720264800233,0.0105277835353616
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30810.Phosphate,48879,-0.00745113329499654,0.00444396439093458,-0.0161613035012283,0.00125903691123524,0.0936197596877264
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30830.SHBG,48748,0.0132553651795494,0.00516432456359152,0.00313328903491,0.0233774413241887,0.0102739776781267
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30840.Total bilirubin,50613,-0.00374543752689547,0.00434505851017568,-0.0122617522068398,0.00477087715304886,0.388697536550837
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30850.Testosterone,48187,0.006238797921922,0.00688160611636853,-0.00724915006616031,0.0197267459100043,0.36463495067383
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30860.Total protein,48902,-0.00372410415142518,0.00416012559729838,-0.01187795032213,0.00442974201927966,0.37069629302798
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30870.Triglycerides,50688,0.0348646173144813,0.00451046913426518,0.0260240978113216,0.0437051368176411,1.12508255217772e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30880.Urate,50673,0.0157631660299798,0.0048428434711289,0.00627119282656719,0.0252551392333925,0.00113591729530273
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30890.Vitamin D,49608,-0.0242733087664904,0.00457217020411118,-0.0332347623665483,-0.0153118551664325,1.11426486396768e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3137.Number of measurements made,49297,-0.0581531687204663,0.0284584600802341,-0.113931750477725,-0.00237458696320739,0.0410218649963326
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3143.Ankle spacing width,41989,0.00860432107135138,0.00693265662515739,-0.00498368591395711,0.0221923280566599,0.214580857964282
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41988,-0.0175096747748486,0.00540955546460953,-0.0281124034854833,-0.00690694606421391,0.0012118377426616
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3146.Speed of sound through heel,41989,-0.0215139537482278,0.00518448598626556,-0.0316755462813083,-0.0113523612151473,3.35095198929984e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41989,-0.0208486993960869,0.00524823115936905,-0.0311352324684503,-0.0105621663237236,7.15062265593699e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3148.Heel bone mineral density (BMD),41977,-0.0203070195092213,0.00525563060470859,-0.0306080554944501,-0.0100059835239924,0.000112160548203052
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X3526.Mother's age at death,47921,-0.000258306700782282,0.00416854366087525,-0.00842865227609777,0.0079120388745332,0.950590813014654
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X3581.Age at menopause (last menstrual period),38292,-0.00141602562976794,0.00567453429466713,-0.0125381128473155,0.00970606158777964,0.802948417481631
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32726,0.0118618769459949,0.00867602832657738,-0.00514313857409673,0.0288668924660866,0.171649229113154
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4100.Ankle spacing width (left),36585,-0.00188377418185628,0.00930570181367199,-0.0201229497366534,0.0163554013729408,0.839584387992367
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36582,-0.0171873793919071,0.00723821820889295,-0.0313742870813373,-0.00300047170247694,0.0175966163500457
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4103.Speed of sound through heel (left),36585,-0.0202782940025711,0.00689595601114084,-0.0337943677844071,-0.00676222022073503,0.00328585665950625
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36585,-0.0197891021809823,0.00699193213231565,-0.033493289160321,-0.00608491520164366,0.00466332556706932
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36582,-0.0194995475298027,0.00697970740202046,-0.0331797740377628,-0.00581932102184256,0.00522351539403901
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36585,-0.0197876588770215,0.00699190277158008,-0.0334917883093184,-0.00608352944472452,0.00466615898054799
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4119.Ankle spacing width (right),36588,-0.0018196135318085,0.00916535826275012,-0.0197837157267987,0.0161444886631817,0.842634596918537
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36587,-0.0135786104281694,0.00721611617289175,-0.0277221981270372,0.000564977270698451,0.0599151732451781
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4122.Speed of sound through heel (right),36588,-0.0139115633547093,0.00687829860113936,-0.0273930286129424,-0.000430098096476133,0.0431575840123323
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36588,-0.0143492417547725,0.00697626588475242,-0.0280227228888872,-0.000675760620657734,0.0397341537607371
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36584,-0.0138989083093644,0.00696533635936745,-0.0275509675737246,-0.000246849045004154,0.0460315989750512
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36588,-0.0143487051018179,0.0069762477154767,-0.0280221506241522,-0.000675259579483554,0.0397410424265796
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4194.Pulse rate,36930,0.00224544748880577,0.00658788813550162,-0.0106668132567774,0.0151577082343889,0.733229669504616
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4195.Pulse wave reflection index,36930,0.00403199141951837,0.00714598238825724,-0.00997413406146583,0.0180381169005026,0.572612659058429
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4196.Pulse wave peak to peak time,36924,0.000866963297407362,0.00650897013683663,-0.0118906181707924,0.0136245447656072,0.894042508206777
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4198.Position of the pulse wave peak,36930,0.0112673456430206,0.00694986156280385,-0.00235438302007495,0.0248890743061161,0.105008409181023
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4199.Position of pulse wave notch,36930,0.0190673426084749,0.00664480242708581,0.00604352985138666,0.0320911553655631,0.00412219182895097
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36930,0.00660446303465068,0.00684252282794752,-0.00680688170812647,0.0200158077774278,0.334470427064976
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4269.Number of triplets attempted (left),36745,-0.0823549429391578,0.10260568776492,-0.283462090958401,0.118752205080085,0.42221088971756
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4270.Volume level set by participant (left),36654,0.0111687379442225,0.0364918317024028,-0.0603552521924869,0.082692728080932,0.759566506731389
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4276.Number of triplets attempted (right),36742,-0.0562703675386085,0.100995265992177,-0.254221088883276,0.141680353806059,0.577435712900142
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4277.Volume level set by participant (right),36647,0.0802477279485081,0.0364317573134754,0.00884148361409633,0.15165397228292,0.0276473876948153
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4288.Time to answer,36931,0.00875942454407068,0.00778367602002495,-0.00649658045517821,0.0240154295433196,0.26047213488276
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4290.Duration screen displayed,36931,0.0242973599851847,0.00734296641540029,0.00990514581100017,0.0386895741593693,0.000940812652746882
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X46.Hand grip strength (left),51699,-0.00854247243744944,0.00567970650291575,-0.0196746971831643,0.00258975230826542,0.132586611375954
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X47.Hand grip strength (right),51725,-0.0110903097787341,0.00564443540792094,-0.0221534031782591,-2.72163792090097e-05,0.0494471343565475
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X48.Waist circumference,51786,0.0375774710101764,0.00861414742276323,0.0206937420615604,0.0544611999587923,1.292737863969e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X4803.Tinnitus,36841,0.0472430711136644,0.0413921020055256,-0.0338854488171657,0.128371591044494,0.253758092253629
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4825.Noisy workplace,36913,0.100856556719702,0.0461062257704478,0.0104883542096243,0.19122475922978,0.028737228077781
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4836.Loud music exposure frequency,36873,0.127430368301513,0.0747283869925657,-0.0190372702039159,0.273898006806942,0.0881887969106349
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X49.Hip circumference,51781,-0.00517229147262071,0.00703382494590376,-0.0189585883665921,0.00861400542135065,0.46213674377184
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X50.Standing height,51762,-0.00227043913269145,0.00558118547227138,-0.0132095626583434,0.00866868439296046,0.684157049113584
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X5057.Number of older siblings,35719,0.00445108959470803,0.0404246126631826,-0.0747811512251299,0.083683330414546,0.912326789741295
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X51.Seated height,51674,0.00118327401423142,0.00521442052385819,-0.00903699021253063,0.0114035382409935,0.82048537248587
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5181.Ever had eye surgery,34398,0.0232562804388906,0.0814379000749657,-0.136362003708042,0.182874564585823,0.775218295341489
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),34384,-0.00386531609832858,0.00785689637895426,-0.0192648330010789,0.0115342008044218,0.622765066865463
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),34384,-0.00606325413048781,0.00808252825754511,-0.0219050095152762,0.00977850125430061,0.453187528681919
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5190.Duration at which refractometer first shown (right),34312,-0.0045581802294885,0.00827198370947402,-0.0207712683000576,0.0116549078410806,0.581631440711571
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5193.Duration at which refractometer first shown (left),34311,-0.00328183308090681,0.00833734186436576,-0.0196230231350637,0.0130593569732501,0.693870168660888
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5199.logMAR, initial (right)",34367,-0.0399343800117419,0.0476464719510615,-0.133321465035822,0.0534527050123385,0.401991211707696
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5200.Final number of letters displayed (right),34367,-0.392047235725265,0.252355109775731,-0.886663250885697,0.102568779435167,0.120352087583441
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5201.logMAR, final (right)",34310,0.00605810081372958,0.00871388939801701,-0.0110211224063838,0.0231373240338429,0.486946813043714
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5202.Number of rounds to result (right),34367,-0.116872652873181,0.0437255324669595,-0.202574696508422,-0.0311706092379402,0.0075441949897767
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5206.logMAR, initial (left)",34364,0.0386193589949843,0.0479497964439723,-0.0553622420352014,0.13260096002517,0.420618805119161
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5207.Final number of letters displayed (left),34364,0.312177349629963,0.272731373339588,-0.22237614211563,0.846730841375557,0.252414195009479
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5208.logMAR, final (left)",34303,0.0121270052114169,0.00867269369451307,-0.00487147442982875,0.0291254848526625,0.162084465905113
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5209.Number of rounds to result (left),34362,-0.0579375003671469,0.0441432114177102,-0.144458194745859,0.0285831940115651,0.189413444225595
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34114,0.0115342160282835,0.00806674433842139,-0.00427660287502244,0.0273450349315894,0.152824224447766
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34114,0.00910632072150219,0.0081617678796896,-0.00689074432268942,0.0251033857656938,0.264592664477921
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5256.Corneal hysteresis (right),34114,-0.00635114692855454,0.00816195840922622,-0.0223485854106379,0.00964629155352885,0.436523857767072
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5257.Corneal resistance factor (right),34114,0.00217844587867069,0.00823387430241304,-0.0139599477540589,0.0183168395114003,0.791350902871701
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34110,0.0178806236547461,0.00805710170818869,0.00208870430669621,0.0336725430027959,0.0265160379496747
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34110,0.0133593799057618,0.00812497953822746,-0.00256557998916405,0.0292843398006876,0.100191504549112
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5264.Corneal hysteresis (left),34110,-0.0153026861732325,0.00828932064529235,-0.0315497546380055,0.00094438229154048,0.0649417727088447
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5265.Corneal resistance factor (left),34110,-0.00257116719204539,0.00831443092471047,-0.0188674518044779,0.0137251174203871,0.757150923697582
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34499,-0.0844729158074115,0.251269215765319,-0.576960578707436,0.408014747092613,0.736744738640767
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51725,-0.000980209162359571,0.0209162984516165,-0.0419761541275279,0.0400157358028087,0.962622502450598
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51725,0.0195403570122711,0.0224406052598608,-0.0244432292970559,0.0635239433215982,0.383895081671174
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51725,-0.0968805159473594,0.0600505311771747,-0.214579557054622,0.0208185251599031,0.10668975664262
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51725,-0.0240936593107373,0.00905136169243128,-0.0418343282279026,-0.00635299039357197,0.00777601862661952
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51725,0.0159688221309456,0.00852420201037713,-0.000738613809393551,0.0326762580712848,0.0610328707445861
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38104,0.00983757172734731,0.0124645303366972,-0.0145929077325792,0.0342680511872739,0.429989663060775
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38104,-0.018331253970265,0.0266818491176641,-0.0706276782408865,0.0339651703003565,0.492081157187522
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38104,0.00208673636253398,0.0328105765285199,-0.0622219936333649,0.0663954663584329,0.949290554112583
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38104,0.0126876285407439,0.0177043665127025,-0.0220129298241529,0.0473881869056408,0.473616039671017
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51795,0.0223958125742744,0.0177342786277292,-0.0123633735360749,0.0571549986846237,0.20665452303826
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51795,0.0223958125742744,0.0177342786277292,-0.0123633735360749,0.0571549986846237,0.20665452303826
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51795,-0.0183731928640629,0.014201596726304,-0.0462083224476187,0.00946193671949296,0.195767999677178
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51795,-0.0101092097369546,0.024485084185892,-0.058099974741303,0.0378815552673938,0.679704191601401
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51795,0.0920938177409188,0.0578094270322869,-0.0212126592423636,0.205400294724201,0.111160979916777
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51795,0.0582304173436595,0.0398892457387112,-0.0199525043042143,0.136413338991533,0.144358283070281
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51795,-0.0227444165937172,0.0653232498333906,-0.150777986267163,0.105289153079728,0.727706324530451
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51725,0.0102934497321626,0.0130908236837527,-0.0153645646879928,0.0359514641523179,0.43169397880927
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51725,0.0075156377297647,0.0221568465250676,-0.0359117814593677,0.0509430569188971,0.73446102745786
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51725,0.00360492775789327,0.0130991405165131,-0.0220693876544724,0.029279243170259,0.783162513134113
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51725,0.00144471400243663,0.0184980525415264,-0.0348114689789552,0.0377008969838284,0.937748508444635
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51725,-0.00233280524949524,0.0225160038695119,-0.0464641728337385,0.041798562334748,0.917482519769148
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51725,0.0382250031594711,0.00875474727558816,0.0210656984993183,0.0553843078196239,1.26988290279768e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38685,0.131626480277204,0.0201153827868349,0.0922003300150078,0.171052630539401,6.31695234881371e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38685,0.0610035201938483,0.0172323167789988,0.0272281793070107,0.0947788610806859,0.000401944225817256
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38685,-0.00421174574137325,0.0248092999905389,-0.0528379737228294,0.0444144822400829,0.865198732234954
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38685,-0.0694396138127917,0.0194995332759817,-0.107658699033716,-0.0312205285918675,0.000371125134389974
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51713,-0.016373837249791,0.0299150988475388,-0.0750074309909671,0.042259756491385,0.584148134285307
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51713,0.0736377467541996,0.0462460610532777,-0.0170045329102247,0.164280026418624,0.111330650638193
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51713,0.148033913313298,0.074065183974876,0.00286615272254062,0.293201673904054,0.0456530704000502
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51713,0.0556565985006284,0.0759119566477512,-0.0931308365289639,0.204444033530221,0.463460540623361
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51713,0.0251217452966245,0.0246496305382263,-0.023191530558299,0.073435021151548,0.308141277228224
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51713,0.0286009964004554,0.0341624842773212,-0.0383574727830942,0.095559465584005,0.402486334892354
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51713,-0.0132163788195071,0.0181073690987832,-0.0487068222531221,0.0222740646141079,0.465465315060504
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35871,0.0117980279409616,0.0244727717531691,-0.0361686046952498,0.0597646605771729,0.629759283539437
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35871,0.211334119151839,0.0257003387461309,0.160961455209422,0.261706783094255,2.3642600562445e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35871,0.0685060979031122,0.035724844379236,-0.00151459708019037,0.138526792886415,0.0552038814997773
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35871,0.00313967812520259,0.0150092934876697,-0.0262785371106301,0.0325578933610352,0.834312331899476
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40329,0.00426067720967473,0.0117550398788177,-0.0187792009528079,0.0273005553721573,0.717018655371758
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40329,-0.0082999193603881,0.0139022057887308,-0.0355482427063004,0.0189484039855242,0.550504991801292
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40329,0.0297147409865908,0.0115019533007559,0.00717091251710923,0.0522585694560724,0.00979434135923961
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40329,-0.0282148652836914,0.0264477770806724,-0.0800525083618093,0.0236227777944266,0.286078854890315
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40329,0.0417252210366076,0.0147893374170016,0.0127381196992846,0.0707123223739307,0.00479134728796741
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40329,-0.0127100175447878,0.0211025244362226,-0.0540709654397841,0.0286509303502084,0.54698776345857
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51725,0.0827025518797067,0.0243998699136527,0.0348788068489474,0.130526296910466,0.000701486844712516
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51725,-0.00152046593600205,0.0184575879692325,-0.0376973383556977,0.0346564064836936,0.934348294064508
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51725,0.0253363602268009,0.0467454262824819,-0.0662846752868635,0.116957395740465,0.587818867385678
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51725,0.0330844877610964,0.0172354452551218,-0.000696984938942352,0.0668659604611351,0.0549259942270677
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51725,0.0656935390440294,0.020325033003801,0.0258564743565794,0.105530603731479,0.00123039479953039
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51725,0.0325231392276032,0.0243607816369485,-0.0152239927808159,0.0802702712360222,0.181869740488854
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51725,-0.00992355891733795,0.00818509784321161,-0.0259663506900327,0.00611923285535681,0.22537452401511
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34788,0.0313234757412778,0.0214323579554334,-0.0106839458513717,0.0733308973339273,0.14393335140723
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34788,0.104885545090386,0.0262844359788211,0.0533680505718964,0.156403039608875,6.68035739627814e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34788,-0.0307297233570281,0.0183964367249536,-0.0667867393379372,0.00532729262388098,0.094892792305174
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34788,-0.0135560224318381,0.0172289233109334,-0.0473247121212676,0.0202126672575913,0.431421894867598
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51819,0.0304727606333287,0.010927174761768,0.00905549810026356,0.0518900231663939,0.00529620386298171
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51819,0.0403431259017362,0.0303071896868386,-0.0190589658844674,0.0997452176879399,0.183156216639855
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51819,0.0145639658949398,0.00909682928692374,-0.00326581950743073,0.0323937512973103,0.109392287683967
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51819,0.0173929050372635,0.00875673230094542,0.00022970972741046,0.0345561003471165,0.047019575366853
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51819,0.000101089514214959,0.0149440615565063,-0.0291892711365375,0.0293914501649674,0.994602788809802
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51819,0.0243576993417581,0.0111853650351377,0.00243438387288821,0.046281014810628,0.0294431373774075
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51819,-0.0176326976653547,0.00915566032531049,-0.0355777919029633,0.000312396572253855,0.0541319491896138
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51819,0.0599599558214037,0.0282014016921766,0.00468520850473745,0.11523470313807,0.0335029091486211
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45278,-0.0149972414062056,0.00939707221663132,-0.033415502950803,0.00342102013839181,0.110519983543444
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45278,-0.00170601839525692,0.00975873203861012,-0.0208331331909328,0.0174210964004189,0.861223525875041
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45278,-0.00809005414867493,0.010329172952258,-0.0283352331351006,0.0121551248377507,0.433507230011008
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45278,0.00291226219468037,0.0141338672820728,-0.0247901176781824,0.0306146420675431,0.836755632100916
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45278,-0.00788405378187447,0.00942132709682646,-0.0263498548916543,0.0105817473279054,0.402700288636238
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51595,0.0252110240392817,0.00960413555907741,0.00638691834348998,0.0440351297350734,0.00867033439816156
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51595,-0.0168227833190067,0.00779005514648223,-0.0320912914061118,-0.00155427523190149,0.0308203912839996
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51595,-0.018116806065347,0.00806632004976768,-0.0339267933628916,-0.00230681876780234,0.0247148946515809
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51595,-0.0379416174475374,0.0175059959954666,-0.0722533695986519,-0.00362986529642286,0.0302186900940907
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51614,-0.0382976160624758,0.00866144314028698,-0.0552740446174382,-0.0213211875075133,9.84236233106687e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51614,2.66161414082245e-05,0.0170895994774728,-0.0334689988344385,0.0335222311172549,0.998757351631493
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51725,-0.0129931413358611,0.00790994063101975,-0.0284966249726598,0.00251034230093761,0.100472533801359
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51725,-0.0312539516315533,0.00907170397093869,-0.0490344914145931,-0.0134734118485134,0.00057164894509939
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51725,0.0126923192116501,0.0137314662145413,-0.0142213545688508,0.0396059929921511,0.355327722869825
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51725,0.0260647999885125,0.0189624078791866,-0.0111015194546933,0.0632311194317182,0.169284305651582
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51725,0.0579199015673285,0.0239284273412469,0.0110201839784845,0.104819619156172,0.0155049958234792
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51725,-0.000575753708726679,0.0225810877925912,-0.0448346857822054,0.043683178364752,0.979658636004138
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41989,-0.0208505760959274,0.00524821476277665,-0.0311370770309697,-0.0105640751608852,7.13953405911812e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X864.Number of days or week walked 10+ minutes,51239,-0.0313780761221289,0.0219543033457658,-0.0744085106798298,0.0116523584355721,0.152948029838017
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X874.Duration of walks,48214,0.00305618786745477,0.00427130449489589,-0.00531556894254117,0.0114279446774507,0.474298873212269
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50314,-0.0482213470015394,0.0212982213659857,-0.0899658608788714,-0.00647683312420747,0.0235779371938449
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X894.Duration of moderate activity,45558,0.013600206403693,0.026122391952722,-0.0375996818236422,0.0648000946310282,0.602628777520074
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33363,-0.0143035438462286,0.00997522210589081,-0.0338549791737746,0.0052478914813174,0.151673712827856
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50227,-0.083357921277591,0.0221773540810861,-0.12682553527652,-0.0398903072786624,0.000171263394846319
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X914.Duration of vigorous activity,40152,-0.00148372280338934,0.00524419659487442,-0.0117623481293432,0.00879490252256452,0.777238434285126
